<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm: Amoxicillin</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 7000 RSS medical sources are combined and output via different filters. This feed contains the latest news and research in the Amoxicillin category.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Amoxicillin&kid=31745&t=Amoxicillin&f=drugs]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 06:38:59 +0100</lastBuildDate>
        <item>
            <title>Actinomycetoma of the chest wall attributed to Nocardia nova after reconstructive surgery.</title>
            <link>http://www.medworm.com/index.php?rid=5663222&amp;cid=c_31745_12_f&amp;fid=31723&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22301041%26dopt%3DAbstract</link>
            <description>Authors: Antunes J, Pacheco D, Travassos R, Sequeira H, Filipe P, Marques MS
    Abstract
    A 29-year-old man, presented with multiple ulcers, nodules, abscesses, fistulae, and atrophic scars, over the right chest wall. Six years prior, the patient had a car accident, which resulted in skin loss of the right arm, shoulder, thoracic wall. In addition, he suffered a supracondylar fracture; orthopedic surgery and skin grafts were required. Material discharging from sinus tracts was obtained for mycological and bacteriological studies. Direct microscopic examination revealed small white grains. Cultures on Sabouraud and Lowenstein-Jensen media isolated orange-white colonies suggestive of Nocardia. PCR assay identified Nocardia nova. Thoracic and right upper limb CT showed signs of chronic os...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Dermatol Online J</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663222</comments>
            <pubDate>Mon, 06 Feb 2012 12:54:18 +0100</pubDate>
            <guid isPermaLink="false">5663222</guid>        </item>
        <item>
            <title>Amoxicillin: Symmetrical drug-related intertriginous and flexural exanthema and fixed drug eruption in a child: case report</title>
            <link>http://www.medworm.com/index.php?rid=5659953&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2012%2F00000001%2F00001387%2Fart00022</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659953</comments>
            <pubDate>Sun, 05 Feb 2012 18:29:54 +0100</pubDate>
            <guid isPermaLink="false">5659953</guid>        </item>
        <item>
            <title>Modification of TiO(2) nanotube surfaces by electro-spray deposition of amoxicillin combined with PLGA for bactericidal effects at surgical implantation sites.</title>
            <link>http://www.medworm.com/index.php?rid=5661409&amp;cid=c_31745_11_f&amp;fid=28233&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22299831%26dopt%3DAbstract</link>
            <description>Conclusions. This study used electro-spray deposition (ESD) methodology to obtain amoxicillin deposition in nanotube structures of TiO(2) and found the optimal deposition time of amoxicillin/PLGA solution simultaneously performing non-toxicity and a high bactericidal effect for preventing early implant failures.
    PMID: 22299831 [PubMed - as supplied by publisher] (Source: Acta Odontologica Scandinavica)</description>
            <author>Acta Odontologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661409</comments>
            <pubDate>Fri, 03 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661409</guid>        </item>
        <item>
            <title>Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.</title>
            <link>http://www.medworm.com/index.php?rid=5649925&amp;cid=c_31745_49_f&amp;fid=35542&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22284248%26dopt%3DAbstract</link>
            <description>CONCLUSION: The levofloxacin-containing sequential therapy is a significantly better strategy than the standard triple treatment for H. pylori eradication. Standard triple treatment is no more effective for H. pylori in our population and levofloxacin-containing sequential regimen might be used as a first-line eradication option.
    PMID: 22284248 [PubMed - in process] (Source: European Journal of Internal Medicine)</description>
            <author>European Journal of Internal Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649925</comments>
            <pubDate>Fri, 03 Feb 2012 00:26:41 +0100</pubDate>
            <guid isPermaLink="false">5649925</guid>        </item>
        <item>
            <title>Amoxicillin: Erythema multiforme: case report</title>
            <link>http://www.medworm.com/index.php?rid=5648155&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2012%2F00000001%2F00001386%2Fart00021</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648155</comments>
            <pubDate>Thu, 02 Feb 2012 18:34:27 +0100</pubDate>
            <guid isPermaLink="false">5648155</guid>        </item>
        <item>
            <title>Multidrug-Resistant, NAP2 Clostridium difficile was the Predominant Toxigenic, Hospital-Acquired Strain in the Province of Manitoba, Canada in 2006-2007.</title>
            <link>http://www.medworm.com/index.php?rid=5658100&amp;cid=c_31745_77_f&amp;fid=37692&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22301615%26dopt%3DAbstract</link>
            <description>The objective of the current study was to determine if the antimicrobial susceptibility profile or genotype of hospital-acquired isolates of Clostridium difficile differed from isolates causing community-acquired disease. Five hundred diarrheal stool samples (&amp;gt;2 ml, one sample per patient) from patients across Manitoba, Canada in 2006-2007 that were reported as C. difficile toxin-positive were cultured and resulted in 432 isolates of toxin-positive C. difficile for analysis. Of the 432 isolates, acquisition status could be determined for 235 (54.4%) isolates; 182 (77.4%) were hospital-acquired and 53 (22.6%) were community-acquired. North American Pulsotype (NAP) designations based on SmaI pulsed-field gel electrophoresis could be defined for 52% of the 432 isolates with NAP2 (n = 122) ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Medical Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5658100</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5658100</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Physicians Total Care, Inc.]</title>
            <link>http://www.medworm.com/index.php?rid=5660093&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D61163</link>
            <description>Updated Date: Feb 2, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660093</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5660093</guid>        </item>
        <item>
            <title>Development and analytical validation of a multivariate calibration method for determination of amoxicillin in suspension formulations by near infrared spectroscopy.</title>
            <link>http://www.medworm.com/index.php?rid=5656807&amp;cid=c_31745_59_f&amp;fid=36096&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22284501%26dopt%3DAbstract</link>
            <description>Authors: Silva MA, Ferreira MH, Braga JW, Sena MM
    Abstract
    This paper proposes a new method for determination of amoxicillin in pharmaceutical suspension formulations, based on transflectance near infrared (NIR) measurements and partial least squares (PLS) multivariate calibration. A complete methodology was implemented for developing the proposed method, including an experimental design, data preprocessing by using multiple scatter correction (MSC) and outlier detection based on high values of leverage, and X and Y residuals. The best PLS model was obtained with seven latent variables in the range from 40.0 to 65.0mgmL(-1) of amoxicillin, providing a root mean square error of prediction (RMSEP) of 1.6mgmL(-1). The method was validated in accordance with Brazilian and international...</description>
            <author>Talanta</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5656807</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5656807</guid>        </item>
        <item>
            <title>Dacryocystitis: Systematic Approach to Diagnosis and Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5649451&amp;cid=c_31745_20_f&amp;fid=35939&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9759511158968425%2F</link>
            <description>The objective of this paper is to review the main findings of the largest studies on the etiopathogenesis and microbiology
 of the development of dacryocystitis and to formulate clinical and surgical guidelines based on said studies and on our experience
 at Cruces Hospital, the Basque Country, Spain. The most common sign of this entity is the distal nasolacrimal duct obstruction,
 and this should be treated to prevent clinical relapse. The time when surgery should be indicated mainly depends on the clinical
 signs and symptoms, age and general status of a patient. Given the germs isolated in cases of dacryocystitis, antibiotic therapy
 against Gram positive (S. aureus, S. pneumoniae, S. epidermidis) and Gram negative bacteria (H. influenzae, P. aeruginosa) should be administered, orally i...</description>
            <author>Current Infectious Disease Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649451</comments>
            <pubDate>Sat, 28 Jan 2012 16:50:36 +0100</pubDate>
            <guid isPermaLink="false">5649451</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Sandoz Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5638664&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D60583</link>
            <description>Updated Date: Jan 26, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638664</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5638664</guid>        </item>
        <item>
            <title>Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP</title>
            <link>http://www.medworm.com/index.php?rid=5624377&amp;cid=c_31745_59_f&amp;fid=37724&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fijmb%2F2012%2F916129%2F</link>
            <description>The selection of antibiotic resistance by cotrimoxazole prophylaxis was evaluated, and we characterized the mechanism of cotrimoxazole resistance in Streptococcus mutans and Streptococcus sobrinus. In vitro susceptibility to six antibiotics was evaluated on 64 mutans streptococci group (MSG) isolates from a cotrimoxazole prophylaxis group and compared to 84 MSG isolates from a nonprophylaxis group. The folA and folP genes were sequenced and compared with reference sequences at NCBI. Only resistance to cotrimoxazole was significantly higher in the prophylaxis group (54.7&amp;#37; versus 15.5&amp;#37;, OR=6.59, 95&amp;#37; CI: 2.89&amp;#8211;15.3, P&amp;lt;0.05). Resistance to amoxicillin, ceftriaxone, chloramphenicol, erythromycin, and tetracycline was 1.4&amp;#37;, 25.5&amp;#37;, 6.2&amp;#37;, 6.5&amp;#37;, and 29.6&amp;#37; of ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>International Journal of Photoenergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5624377</comments>
            <pubDate>Tue, 24 Jan 2012 18:18:57 +0100</pubDate>
            <guid isPermaLink="false">5624377</guid>        </item>
        <item>
            <title>Accelerated Growth Rate Induced by Neonatal High-Protein Milk Formula Is Not Supported by Increased Tissue Protein Synthesis in Low-Birth-Weight Piglets</title>
            <link>http://www.medworm.com/index.php?rid=5624381&amp;cid=c_31745_59_f&amp;fid=37724&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fjnume%2F2012%2F545341%2F</link>
            <description>In conclusion, accelerated growth rate caused by high protein formula and antibiotics was not supported by increased protein synthesis in muscle and carcass. (Source: International Journal of Photoenergy)</description>
            <author>International Journal of Photoenergy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5624381</comments>
            <pubDate>Tue, 24 Jan 2012 18:18:57 +0100</pubDate>
            <guid isPermaLink="false">5624381</guid>        </item>
        <item>
            <title>Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: Association with distinct demographic groups in the community in New Zealand</title>
            <link>http://www.medworm.com/index.php?rid=5636015&amp;cid=c_31745_77_f&amp;fid=33419&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F333172j47803j956%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Extended spectrum beta-lactamase producing E. coli (ESBL-EC) are an emerging public health issue. In New Zealand (NZ), bla
 CTX-M-14 and bla
 CTX-M-15 are the most common ESBL genes. Although many studies describe risk factors for ESBL-EC, few describe risk factors for specific
 ESBL genes. Between January 2006 and December 2007, we characterized 108 consecutive, non-duplicate isolates of ESBL-EC at
 the Auckland Hospital laboratory. Demographic and clinical data were recorded. Of the 108, 54.6% (59) were CTX-M-15-EC, 26.9%
 (29) were CTX-M-14-EC and 12.09% were CTX-M-9 (13). The remaining seven isolates carried CTX-M-3 (3; 2.7%), CTX-M-65 (2; 1.8%),
 CTX-M-27 (1; 0.9%) and CTX-M-57 (1; 0.9%). CTX-M-15-EC were more likely than CTX-M-14-EC to be fluoroquinolone-resistant...</description>
            <author>European Journal of Clinical Microbiology and Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636015</comments>
            <pubDate>Tue, 24 Jan 2012 06:53:27 +0100</pubDate>
            <guid isPermaLink="false">5636015</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [NorthStar Rx LLC]</title>
            <link>http://www.medworm.com/index.php?rid=5628978&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D60330</link>
            <description>Updated Date: Jan 24, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628978</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5628978</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Aurobindo Pharma Limited]</title>
            <link>http://www.medworm.com/index.php?rid=5628988&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D60341</link>
            <description>Updated Date: Jan 24, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628988</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5628988</guid>        </item>
        <item>
            <title>Amoxicillin/clavulanic acid: Clostridium difficile infection causing diarrhoea: case report</title>
            <link>http://www.medworm.com/index.php?rid=5620307&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2012%2F00000001%2F00001385%2Fart00025</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620307</comments>
            <pubDate>Mon, 23 Jan 2012 18:35:21 +0100</pubDate>
            <guid isPermaLink="false">5620307</guid>        </item>
        <item>
            <title>First‐day step‐down to oral outpatient treatment versus continued standard treatment in children with cancer and low‐risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study</title>
            <link>http://www.medworm.com/index.php?rid=5628130&amp;cid=c_31745_6_f&amp;fid=33611&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fpbc.24076</link>
            <description>ConclusionsIn children with low‐risk FN, the efficacy of first‐day step‐down to oral antimicrobial therapy with amoxicillin and ciprofloxacin in an outpatient setting was non‐inferior to continued hospitalization and intravenous antimicrobial therapy. The safety of this procedure, however, was not assessable with sufficient power. Pediatr Blood Cancer © 2012 Wiley Periodicals, Inc. (Source: Pediatric Blood and Cancer)</description>
            <author>Pediatric Blood and Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628130</comments>
            <pubDate>Mon, 23 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5628130</guid>        </item>
        <item>
            <title>Epidemiological, clinical features and susceptibility pattern of shigellosis in the Buea Health District, Cameroon</title>
            <link>http://www.medworm.com/index.php?rid=5612957&amp;cid=c_31745_39_f&amp;fid=37719&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2Fcontent%2F5%2F1%2F54</link>
            <description>Conclusion:
Shigellosis is more prevalent in children below 15 years in the Buea District. There is a high level of resistance to most of the antibiotics used for the treatment of shigellosis including extended-spectrum beta-lactamases (ESBLs) as well as evidence of resistance to quinolones. Azithromycin was found to be the drug of choice for shigellosis in this setting. (Source: BMC Research Notes)</description>
            <author>BMC Research Notes</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612957</comments>
            <pubDate>Sat, 21 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5612957</guid>        </item>
        <item>
            <title>The use of amoxicillin and clavulanic acid and quinolones as first choice antibiotics in uncomplicated urinary tract infections in Spain should be reviewed.</title>
            <link>http://www.medworm.com/index.php?rid=5629386&amp;cid=c_31745_35_f&amp;fid=37560&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22265580%26dopt%3DAbstract</link>
            <description>Authors: Llor C, Aspiroz C, Cano A, Barranco M
    PMID: 22265580 [PubMed - as supplied by publisher] (Source: Atencion Primaria)</description>
            <author>Atencion Primaria</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629386</comments>
            <pubDate>Fri, 20 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629386</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMpowder, For Suspension [NorthStar Rx LLC]</title>
            <link>http://www.medworm.com/index.php?rid=5609264&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D59965</link>
            <description>Updated Date: Jan 18, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5609264</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5609264</guid>        </item>
        <item>
            <title>Acute generalized exanthematous pustulosis to amoxicillin associated with parvovirus B19 reactivation.</title>
            <link>http://www.medworm.com/index.php?rid=5617795&amp;cid=c_31745_57_f&amp;fid=38083&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22257115%26dopt%3DAbstract</link>
            <description>We report the case of a 22-year-old male patient with 2 episodes, 4 months apart, of acute generalized exanthematous pustulosis (AGEP) associated with oral intake of amoxicillin and simultaneous reactivation of parvovirus B19 infection proven by positive polymerase chain reaction test in the skin fragment and blood sample and elevation of the IgG antibodies titer. To our knowledge, this is the first report of AGEP resulting from the interaction between drug hypersensitivity and the reactivation of parvovirus B19. A combination of an immunological reaction to the drug and virus infection could be responsible for the clinical picture.
    PMID: 22257115 [PubMed - as supplied by publisher] (Source: Cutaneous and Ocular Toxicology)</description>
            <author>Cutaneous and Ocular Toxicology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5617795</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5617795</guid>        </item>
        <item>
            <title>Duration of Dual Amoxicillin Plus Omeprazole for H. Pylori Duration of Dual Amoxicillin Plus Omeprazole for H. Pylori</title>
            <link>http://www.medworm.com/index.php?rid=5601800&amp;cid=c_31745_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756513%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756513%3Fsrc%3Drss</link>
            <description>How long should a patient with H. pylori disease be treated with a combination of an antibiotic and a proton pump inhibitor? This new study investigates.  Journal of Gastroenterology and Hepatology (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5601800</comments>
            <pubDate>Wed, 18 Jan 2012 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5601800</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Preferred Pharmaceuticals, Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5582588&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D59738</link>
            <description>Updated Date: Jan 13, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582588</comments>
            <pubDate>Fri, 13 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5582588</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMpowder [CBSCHEM LIMITD]</title>
            <link>http://www.medworm.com/index.php?rid=5582613&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D59763</link>
            <description>Updated Date: Jan 13, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582613</comments>
            <pubDate>Fri, 13 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5582613</guid>        </item>
        <item>
            <title>A Comparison of the Prevalence and Antimicrobial Resistance of Escherichia coli from Different Retail Meats in the United States: 2002-2008.</title>
            <link>http://www.medworm.com/index.php?rid=5597670&amp;cid=c_31745_77_f&amp;fid=37539&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247155%26dopt%3DAbstract</link>
            <description>Authors: Zhao S, Blickenstaff K, Bodeis-Jones S, Gaines SA, Tong E, McDermott PF
    Abstract
    Escherichia coli were recovered from the National Antimicrobial Resistance Monitoring System retail meat program and examined for antimicrobial susceptibility. Retail meat samples (N= 11,921) from four U.S. states collected during 2002-2008 were analyzed, consisting of 2,988 chicken breast, 2,942 ground turkey, 2,991 ground beef and 3,000 pork chops. A total of 8,286 E. coli were recovered. Most chicken (83.5%) and turkey (82.0%) were contaminated with the organism, followed by beef (68.9%) and pork (44.0%). Resistance to tetracycline was most common (50.3%), followed by streptomycin (34.6%), sulfamethoxazole/sulfisoxazole (31.6%), ampicillin (22.5%), gentamicin (18.6%), kanamycin (8.4%), amox...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Applied and Environmental Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597670</comments>
            <pubDate>Fri, 13 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5597670</guid>        </item>
        <item>
            <title>Question 1 Do febrile convulsions cause CSF pleocytosis?</title>
            <link>http://www.medworm.com/index.php?rid=5585732&amp;cid=c_31745_33_f&amp;fid=32752&amp;url=http%3A%2F%2Fadc.bmj.com%2Fcgi%2Fcontent%2Fshort%2F97%2F2%2F172-b%3Frss%3D1</link>
            <description>Scenario You are asked to review a previously healthy 11-month-old boy who presented to the Accident and Emergency department following a generalised convulsion lasting 7 min. His parents tell you that he was started on oral amoxicillin by his general practitioner 2 days ago, the reason for which is unclear. Clinical examination reveals a drowsy child with a temperature of 38.8&amp;deg;C. In the absence of a clear focus of infection you decide to do a full septic screen, including a lumbar puncture (LP). Cerebrospinal fluid (CSF) analysis shows a white blood cell count (WCC) of 17x106/l, a protein concentration within normal limits and no bacteria on a Gram stain. You wonder if the mild CSF pleocytosis indicates partially treated meningitis or can be attributed to the convulsion alone. Structu...</description>
            <author>Archives of Disease in Childhood</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5585732</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5585732</guid>        </item>
        <item>
            <title>Children diagnosed with otitis media by an otoscopist benefited from antibiotics but suffered more side effects</title>
            <link>http://www.medworm.com/index.php?rid=5585772&amp;cid=c_31745_33_f&amp;fid=32763&amp;url=http%3A%2F%2Fep.bmj.com%2Fcgi%2Fcontent%2Fshort%2F97%2F1%2F38%3Frss%3D1</link>
            <description>Study designDesign Randomised placebo-controlled trial. Allocation Allocation sequence computer-generated random number list. Blinding Physicians, parents/caregivers.  Study questionSetting Southwest Finland, community based. Patients 319 children aged 6&amp;ndash;35 months diagnosed with acute otitis media by a qualified otoscopist. Intervention 161 infants assigned to amoxicillin&amp;ndash;clavulanate 40 mg/kg/dose (clavulanate 5.7 mg/kg) for 7 days. 158 assigned to placebo. Outcomes Primary outcome was treatment failure (no overall improvement, no improvement in otoscopic signs, perforation, severe infection requiring antibiotics, adverse reaction); secondary outcomes included time to initiation of open label antibiotics and the development of contralateral otitis media. Follow-up period Until ...</description>
            <author>Archives of Disease in Childhood - Education and Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5585772</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5585772</guid>        </item>
        <item>
            <title>Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.</title>
            <link>http://www.medworm.com/index.php?rid=5619604&amp;cid=c_31745_77_f&amp;fid=34508&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261518%26dopt%3DAbstract</link>
            <description>Authors: Treviño M, Areses P, Dolores Peñalver M, Cortizo S, Pardo F, Luisa Pérez Del Molino M, García-Riestra C, Hernández M, Llovo J, Regueiro BJ
    Abstract
    Susceptibility testing of clinical isolates of anaerobic bacteria is not considered, often, mandatory in routine clinical practice and the treatments are empirically established. Thus, periodic monitoring of the susceptibility patterns of anaerobic bacteria is advisable. The aim of this study was to update on resistance of Bacteroides fragilis group in our Institution with special attention to carbapenems reporting metallo-beta-lactamase producing strains for the first time in Spain, and to compare fingerprinting analysis results obtained by using automated rep-PCR (DiversiLab System) and MALDI-TOF MS. A total of 830 non-d...</description>
            <author>Anaerobe</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5619604</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5619604</guid>        </item>
        <item>
            <title>Lansoprazole‐based sequential and concomitant therapy for the first‐line Helicobacter pylori eradication</title>
            <link>http://www.medworm.com/index.php?rid=5583138&amp;cid=c_31745_17_f&amp;fid=30390&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1751-2980.2012.00575.x</link>
            <description>CONCLUSION:  The first‐line lansoprazole‐based sequential therapy and concomitant therapy were well‐tolerated and comparable in terms of H. pylori eradication rate.© 2012 The Author. Journal of Digestive Diseases © 2012 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd. (Source: Chinese Journal of Digestive Diseases)</description>
            <author>Chinese Journal of Digestive Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583138</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5583138</guid>        </item>
        <item>
            <title>A Comparison between Sequential Therapy and a Modified Bismuth‐based Quadruple Therapy for Helicobacter pylori Eradication in Iran: A Randomized Clinical Trial</title>
            <link>http://www.medworm.com/index.php?rid=5560960&amp;cid=c_31745_17_f&amp;fid=30385&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1523-5378.2011.00896.x</link>
            <description>Conclusion:  Because the two regimens showed acceptable and similar abilities in H. pylori eradication and because of much higher cost of clarithromycin in Iran, the furazolidone containing regimen seems to be superior. Further modifications of sequential therapies are needed to make them ideal regimens in developing countries. (Source: Helicobacter)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Helicobacter</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5560960</comments>
            <pubDate>Thu, 05 Jan 2012 16:46:00 +0100</pubDate>
            <guid isPermaLink="false">5560960</guid>        </item>
        <item>
            <title>Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial.</title>
            <link>http://www.medworm.com/index.php?rid=5579593&amp;cid=c_31745_11_f&amp;fid=28257&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22220822%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Systemic administration of metronidazole and amoxicillin as an adjunct to OSFMD therapy significantly improved clinical and microbiological outcomes in patients with G-AgP over a 6-month period.
    PMID: 22220822 [PubMed - as supplied by publisher] (Source: Journal of Clinical Periodontology)</description>
            <author>Journal of Clinical Periodontology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579593</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579593</guid>        </item>
        <item>
            <title>Experience developing national evidence based clinical guidelines for childhood pneumonia in a low-income setting - making the GRADE?</title>
            <link>http://www.medworm.com/index.php?rid=5562753&amp;cid=c_31745_33_f&amp;fid=34043&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1471-2431%2F12%2F1</link>
            <description>Conclusions:
Although this exercise may have fallen short of the rigorous requirements recommended by the developers of GRADE, it was arguably an improvement on previous attempts at guideline development in low-income countries and offers valuable lessons for future similar exercises where resources and locally-generated evidence are scarce. (Source: BMC Pediatrics - Latest articles)</description>
            <author>BMC Pediatrics  - Latest articles</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562753</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562753</guid>        </item>
        <item>
            <title>Antimicrobials for aggressive periodontitis</title>
            <link>http://www.medworm.com/index.php?rid=5659790&amp;cid=c_31745_11_f&amp;fid=38396&amp;url=http%3A%2F%2Fwww.dentalabstracts.com%2Farticle%2FPIIS0011848611001749%2Fabstract%3Frss%3Dyes</link>
            <description>In generalized aggressive periodontitis (GAgP), there is severe destruction of the supporting structures of the teeth that can cause edentulism early in life. This is a relatively rare disorder and little studied. Treatment approaches begin with a cause-related treatment phase aimed at reducing and/or eliminating pathogenic microorganisms. Systemic antimicrobials may also prove beneficial. A 7-day adjunctive course of systemic metronidazole and amoxicillin significantly improved the short-term clinical outcomes in patients with GAgP who underwent nonsurgical debridement. However, in clinical practice, antimicrobials are more likely to be used for retreatment than for initial therapy. An investigation was undertaken to determine whether retreatment with adjunctive antimicrobials achieves th...</description>
            <author>Dental Abstracts</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659790</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659790</guid>        </item>
        <item>
            <title>Long-term trends in the epidemiology and resistance of childhood bacterial enteropathogens in Crete</title>
            <link>http://www.medworm.com/index.php?rid=5569738&amp;cid=c_31745_77_f&amp;fid=33419&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1n4v0t1w12751507%2F</link>
            <description>In this study, we investigated the long-term trends in the epidemiology and susceptibility of bacterial enteropathogens among
 children in a well-defined area of adequate health standards. The study included all children younger than 14 years of age
 treated for enteritis at Heraklion University General Hospital on the island of Crete during the 18-year period from January
 1993 to December 2010. Stool specimens were tested for Salmonella, Shigella, Campylobacter, enteropathogenic Escherichia coli (EPEC), Yersinia, and Aeromonas species. Of the 33,032 stool samples from patients of any age, 2,912 (8.82%) were positive for bacterial enteropathogens.
 The 1,597 isolates from children were identified as S. enterica (42.3%), Campylobacter spp. (33.6%), EPEC (17.4%), Y. enterocolitica (5.82%), ...</description>
            <author>European Journal of Clinical Microbiology and Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5569738</comments>
            <pubDate>Fri, 30 Dec 2011 06:51:16 +0100</pubDate>
            <guid isPermaLink="false">5569738</guid>        </item>
        <item>
            <title>Moxifloxacin or Amoxicillin/clavulanate Effective for COPDMoxifloxacin or Amoxicillin/clavulanate Effective for COPD</title>
            <link>http://www.medworm.com/index.php?rid=5545896&amp;cid=c_31745_26_f&amp;fid=23294&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756094%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756094%3Fsrc%3Drss</link>
            <description>Moxifloxacin was as effective as amoxicillin/clavulanic acid for chronic obstructive pulmonary disease (COPD) exacerbations in outpatients in the MAESTRAL trial.  Reuters Health Information (Source: Medscape Medical News Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Medical News Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5545896</comments>
            <pubDate>Wed, 28 Dec 2011 19:14:29 +0100</pubDate>
            <guid isPermaLink="false">5545896</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [H.J. Harkins Company, Inc.]</title>
            <link>http://www.medworm.com/index.php?rid=5544736&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D58623</link>
            <description>Updated Date: Dec 27, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544736</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544736</guid>        </item>
        <item>
            <title>Moxifloxacin or amoxicillin/clavulanate effective for COPD exacerbations</title>
            <link>http://www.medworm.com/index.php?rid=5545470&amp;cid=c_31745_22_f&amp;fid=38164&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FModern%2BMedicine%2BNow%2FMoxifloxacin-or-amoxicillinclavulanate-effective-f%2FArticleNewsFeed%2FArticle%2Fdetail%2F754161%3Fref%3D25</link>
            <description>NEW YORK (Reuters Health) - Moxifloxacin was as effective as amoxicillin/clavulanic acid for chronic
  obstructive pulmonary disease (COPD) exacerbations in outpatients in the MAESTRAL trial. (Source: Modern Medicine)</description>
            <author>Modern Medicine</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5545470</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5545470</guid>        </item>
        <item>
            <title>Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD Surveillance Study.</title>
            <link>http://www.medworm.com/index.php?rid=5559025&amp;cid=c_31745_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22203594%26dopt%3DAbstract</link>
            <description>Authors: Karlowsky JA, Walkty AJ, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG
    Abstract
    Clinical isolates of Bacteroides fragilis group (n = 387) were collected from patients attending nine Canadian hospitals in 2010-2011 and tested for susceptibility to 10 antimicrobial agents using the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method. B. fragilis (59.9%), Bacteroides ovatus (16.3%), and Bacteroides thetaiotamicron (12.7%) accounted for ∼90% of isolates collected. Overall rates of percent susceptibility were: 99.7%, metronidazole; 99.5%, piperacillin-tazobactam; 99.2% imipenem; 97.7%, ertapenem; 92.0%, doripenem; 87.3%, amoxicillin-clavulanate; 80.9%, tigecycline; 65.9%, cefoxitin; 55.6%, moxifloxacin; and 52.2%, clindamycin. Percent susceptibility to cef...</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559025</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5559025</guid>        </item>
        <item>
            <title>Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: A pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5525813&amp;cid=c_31745_17_f&amp;fid=30386&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1440-1746.2011.06876.x</link>
            <description>Conclusion:  Despite the theory and pre‐existing data from Japan, in the USA, prolonging the duration of dual amoxicillin‐PPI therapy did not improve treatment outcome in 90% or more of our patients. (Source: Journal of Gastroenterology and Hepatology)</description>
            <author>Journal of Gastroenterology and Hepatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5525813</comments>
            <pubDate>Thu, 22 Dec 2011 09:16:04 +0100</pubDate>
            <guid isPermaLink="false">5525813</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Lake Erie Medical Surgical Supply DBA Quality Care Products LLC]</title>
            <link>http://www.medworm.com/index.php?rid=5538232&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D58487</link>
            <description>Updated Date: Dec 22, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538232</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538232</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMpowder, For Suspension [Aurobindo Pharma Limited]</title>
            <link>http://www.medworm.com/index.php?rid=5538246&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D58501</link>
            <description>Updated Date: Dec 22, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538246</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538246</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]</title>
            <link>http://www.medworm.com/index.php?rid=5525183&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D58330</link>
            <description>Updated Date: Dec 20, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5525183</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5525183</guid>        </item>
        <item>
            <title>Pharmacokinetic Effects of Bariatric Surgery (January).</title>
            <link>http://www.medworm.com/index.php?rid=5537770&amp;cid=c_31745_13_f&amp;fid=37308&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22190251%26dopt%3DAbstract</link>
            <description>CONCLUSIONS:Bariatric surgical procedures may result in altered pharmacokinetic parameters, but the literature is lacking in sufficient quantity and quality of studies to make solid conclusions and recommendations. Until more studies of sufficient power are completed, clinicians should closely monitor these patients in the immediate and distant postsurgical period for signs of both drug efficacy and toxicity and adjust their medications as required.
    PMID: 22190251 [PubMed - as supplied by publisher] (Source: The Annals of Pharmacotherapy)</description>
            <author>The Annals of Pharmacotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537770</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5537770</guid>        </item>
        <item>
            <title>Call to boost child penicillin doses</title>
            <link>http://www.medworm.com/index.php?rid=5527173&amp;cid=c_31745_26_f&amp;fid=23300&amp;url=http%3A%2F%2Fwww.nhs.uk%2Fnews%2F2011%2F12December%2FPages%2Fcall-to-boost-penicillin-dose-in-children.aspx</link>
            <description>Conclusion
This was a narrative review of an important area of medicine: the appropriate prescription of antibiotics for children. The authors’ call for an evidence-based update of prescribing guidelines appears to be well founded, particularly as dosing guidelines for adult penicillin and related antibiotics have been updated several times over the last 50 years. During this time, adult doses have increased substantially. The authors say it is time for the same type of review to be applied to children’s dosage guidelines, and this would be likely to support increasing the doses given to children.
While this narrative review has highlighted the evidence behind the current guidelines for prescribing penicillins to children, and suggested ways these can be updated and improved, it is not...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>NHS News Feed</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527173</comments>
            <pubDate>Mon, 19 Dec 2011 17:00:00 +0100</pubDate>
            <guid isPermaLink="false">5527173</guid>        </item>
        <item>
            <title>Strychnine in amoxicillin capsules: A means of homicide. - Kodikara S.</title>
            <link>http://www.medworm.com/index.php?rid=5510146&amp;cid=c_31745_46_f&amp;fid=34959&amp;url=http%3A%2F%2Fwww.safetylit.org%2Fcitations%2Findex.php%3Ffuseaction%3Dcitations.viewdetails%26citationIds%5B%5D%3Dcitjournalarticle_337892_10</link>
            <description>Fatal strychnine poisoning is uncommon. It is no longer used as a therapeutic drug and its availability to the public is controlled by legislations in various jurisdictions, but it is still in use as a rodenticide and an adulterant in street drugs. Homicid... (Source: SafetyLit: All (Unduplicated))</description>
            <author>SafetyLit: All (Unduplicated)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5510146</comments>
            <pubDate>Sat, 17 Dec 2011 00:35:12 +0100</pubDate>
            <guid isPermaLink="false">5510146</guid>        </item>
        <item>
            <title>Amoxicillin/antiepileptic drugs/sulfonamides: Stevens Johnson syndrome: 5 case reports</title>
            <link>http://www.medworm.com/index.php?rid=5505112&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001381%2Fart00017</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5505112</comments>
            <pubDate>Fri, 16 Dec 2011 06:55:18 +0100</pubDate>
            <guid isPermaLink="false">5505112</guid>        </item>
        <item>
            <title>BMJ feature: Time to abandon historical rule of thumb for dosing of oral penicillins in children?</title>
            <link>http://www.medworm.com/index.php?rid=5515704&amp;cid=c_31745_13_f&amp;fid=38936&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2011---December%2F16%2FBMJ-feature-Time-to-abandon-historical-rule-of-thumb-for-dosing-of-oral-penicillins-in-children%2F</link>
            <description>Source: British Medical Journal (BMJ)
Area: News
 In this BMJ feature, the 'Improving Children's Antibiotic Prescribing UK Research Network' suggests it's time to abandon the historical rule of thumb for dosing of oral penicillins in children. 
 &amp;#160; 
 The authors note that despite their wide use over many decades, guidance on the correct dose of oral penicillins for children remains confusing: the SPC for Amoxil paediatric suspension in children weighing &amp;#60;40 kg is 40-90 mg/kg/day for all indications, whereas recommendations for amoxicillin, penicillin V, and flucloxacillin in the BNF-C are mostly based on age bands, although weight bands or weight based calculations (mg/kg) are given for some indications. The widely used doses of 62.5 mg or 125 mg are fractions of the adult dose rec...</description>
            <author>NeLM - News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515704</comments>
            <pubDate>Fri, 16 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515704</guid>        </item>
        <item>
            <title>Heavier children leads to call for drug dose update</title>
            <link>http://www.medworm.com/index.php?rid=5511301&amp;cid=c_31745_58_f&amp;fid=36473&amp;url=http%3A%2F%2Fwww.guardian.co.uk%2Fsociety%2F2011%2Fdec%2F16%2Fheavier-children-drug-dose-guidelines</link>
            <description>Guidelines on prescribing antibiotics need to be updated, says group of doctors and scientistsMedicines experts are calling for a review of the 50-year-old guidelines on prescribing antibiotics to children, warning that the rise in overweight and obese youngsters may mean that some get a less than adequate dose.While they stress that there is no evidence that children are suffering as a result of under-treatment, they say there should be better guidance than the rule of thumb that has applied for half a century.Since the 1960s, doctors have worked on the principle that a big child is equal to half an adult, a small child is equal to half a big child and a baby is equal to half a small child, say a group of doctors and scientists in the British Medical Journal.The problem lies with the pres...</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5511301</comments>
            <pubDate>Fri, 16 Dec 2011 00:05:00 +0100</pubDate>
            <guid isPermaLink="false">5511301</guid>        </item>
        <item>
            <title>amoxicillin and clavulanic acid, Augmentin, Augmentin XR</title>
            <link>http://www.medworm.com/index.php?rid=5505048&amp;cid=c_31745_13_f&amp;fid=32557&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D699%26k%3DMedications_General</link>
            <description>Title: amoxicillin and clavulanic acid, Augmentin, Augmentin XRCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 12/15/2011 (Source: MedicineNet Medications General)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedicineNet Medications General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5505048</comments>
            <pubDate>Thu, 15 Dec 2011 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5505048</guid>        </item>
        <item>
            <title>Malaria therapy in HIV: drug interactions between nevirapine and quinine</title>
            <link>http://www.medworm.com/index.php?rid=5510249&amp;cid=c_31745_46_f&amp;fid=37239&amp;url=http%3A%2F%2Fijsa.rsmjournals.com%2Fcgi%2Fcontent%2Fshort%2F22%2F12%2F768%3Frss%3D1</link>
            <description>We report the case of an HIV-positive Nigerian man on antiretroviral therapy (ART) with an undetectable viral load who presented with rigors, fever and back pain after returning to the UK from a three-week trip to Nigeria. Infection with Plasmodium falciparum malaria was confirmed and treatment with quinine commenced together with amoxicillin/clavulanic acid and clarithromycin for possible respiratory infection. At the time of admission the patient could not remember the names of his ART medications. After 24 hours his parasitaemia had increased from 1% to 2.5% and his clinical condition had deteriorated. At this point, his ART was identified as abacavir, lamivudine and nevirapine. The Liverpool HIV-drug interactions website was checked for drug interactions. It recommends caution in the c...</description>
            <author>International Journal of STD and AIDS</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5510249</comments>
            <pubDate>Thu, 15 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5510249</guid>        </item>
        <item>
            <title>Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum {beta}-lactamase production in clinical Enterobacteriaceae isolates</title>
            <link>http://www.medworm.com/index.php?rid=5501705&amp;cid=c_31745_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F67%2F1%2F159%3Frss%3D1</link>
            <description>Conclusions
EUCAST non-susceptible breakpoints for ceftazidime and cefpodoxime detect more ESBL-producing Enterobacteriaceae isolates compared with corresponding CLSI ESBL screening breakpoints. Implementation of the cefepime DAM can facilitate ESBL screening, especially in strains producing an AmpC &amp;beta;-lactamase since the test shows high sensitivity and specificity. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5501705</comments>
            <pubDate>Mon, 12 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5501705</guid>        </item>
        <item>
            <title>Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain</title>
            <link>http://www.medworm.com/index.php?rid=5501707&amp;cid=c_31745_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F67%2F1%2F170%3Frss%3D1</link>
            <description>Conclusions
Our study confirms an increasing rate of resistance to levofloxacin that equals that of clarithromycin in our healthcare area. This fact may reflect a wide and indiscriminate use of the former antibiotic and could account for a loss of clinical effectiveness of levofloxacin-containing regimens. Moreover, clarithromycin resistance rates remain stable, which could allow us to maintain its use in our area. (Source: Journal of Antimicrobial Chemotherapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5501707</comments>
            <pubDate>Mon, 12 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5501707</guid>        </item>
        <item>
            <title>Comparison of antimicrobial resistance patterns of Salmonella spp. and Escherichia coli recovered from pet dogs from volunteer households in Ontario (2005-06)</title>
            <link>http://www.medworm.com/index.php?rid=5501708&amp;cid=c_31745_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F67%2F1%2F174%3Frss%3D1</link>
            <description>Conclusions
Pet dogs are a potential household source of antimicrobial-resistant Salmonella spp. and E. coli. However, extrapolating the epidemiology of antimicrobial resistance in pathogens, like Salmonella, from E. coli should be done with caution. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5501708</comments>
            <pubDate>Mon, 12 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5501708</guid>        </item>
        <item>
            <title>Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea</title>
            <link>http://www.medworm.com/index.php?rid=5486995&amp;cid=c_31745_13_f&amp;fid=32540&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2125.2011.04048.x</link>
            <description>CONCLUSIONSBecause dual therapy had fewer side effects than triple therapy and a similar eradication rate, dual therapy may provide an acceptable alternative first line therapy for H. pylori eradication in Korea. (Source: British Journal of Clinical Pharmacology)</description>
            <author>British Journal of Clinical Pharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486995</comments>
            <pubDate>Sat, 10 Dec 2011 06:49:14 +0100</pubDate>
            <guid isPermaLink="false">5486995</guid>        </item>
        <item>
            <title>Strychnine in amoxicillin capsules: A means of homicide</title>
            <link>http://www.medworm.com/index.php?rid=5484291&amp;cid=c_31745_142_f&amp;fid=37937&amp;url=http%3A%2F%2Fwww.jflmjournal.org%2Farticle%2FPIIS1752928X11001557%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Fatal strychnine poisoning is uncommon. It is no longer used as a therapeutic drug and its availability to the public is controlled by legislations in various jurisdictions, but it is still in use as a rodenticide and an adulterant in street drugs. Homicide by strychnine is extremely rare. As the autopsy findings are subtle, strychnine poisoning could easily be overlooked and a homicide may go undetected. This communication highlights an unusual case of homicide by strychnine. It is important that in deaths where there are no gross autopsy findings, sudden death in particular, that routine toxicology be performed, in which strychnine is likely to be detected. (Source: Journal of Forensic and Legal Medicine)</description>
            <author>Journal of Forensic and Legal Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5484291</comments>
            <pubDate>Thu, 08 Dec 2011 19:14:42 +0100</pubDate>
            <guid isPermaLink="false">5484291</guid>        </item>
        <item>
            <title>[Chronic subdural hematoma infected by Campylobacter fetus: Case report.]</title>
            <link>http://www.medworm.com/index.php?rid=5534521&amp;cid=c_31745_153_f&amp;fid=36795&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22154423%26dopt%3DAbstract</link>
            <description>We report here a rare case of chronic subdural hematoma infected by Campylobacter fetus in a 86-year-old woman. She was admitted for confusion and disorientation in a context of high fever and diarrhoea. After two surgeries, the evolution was finally good with a combination of antibiotics (amoxicillin and clindamycin). Chronic subdural hematoma is a potential site for bacterial infection. Our case suggests that C. fetus infection should be suspected in elderly patients presenting with fever and enteritis. The frequency of such cases may be underestimated, due to the difficult diagnosis of C. fetus. It is also suspected that C. fetus could play a role in the recurrence of hematoma, because of its vessel tropism.
    PMID: 22154423 [PubMed - as supplied by publisher] (Source: Neuro-Chirur...</description>
            <author>Neuro-Chirurgie</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5534521</comments>
            <pubDate>Wed, 07 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5534521</guid>        </item>
        <item>
            <title>[Stability and compatibility of acetaminophen, ketoprofen and amoxicillin in a fail-safe intravenous administration set.]</title>
            <link>http://www.medworm.com/index.php?rid=5514660&amp;cid=c_31745_5_f&amp;fid=34510&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22152998%26dopt%3DAbstract</link>
            <description>CONCLUSION: Despite the technical innovation of a fail-safe intravenous administration set, we have to stay aware of mixture consequences in intravenous infusion field.
    PMID: 22152998 [PubMed - as supplied by publisher] (Source: Annales Francaises d'Anesthesie et de Reanimation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Annales Francaises d'Anesthesie et de Reanimation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5514660</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5514660</guid>        </item>
        <item>
            <title>Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option</title>
            <link>http://www.medworm.com/index.php?rid=5469637&amp;cid=c_31745_17_f&amp;fid=37422&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0004-28032011000400008%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>CONCLUSION: Due to the low amoxicillin and clarithromycin resistance observed in this study, therapies using these antimicrobials remain appropriated first-line H. pylori therapy.CONTEXTO: A susceptibilidade aos antibióticos é a pedra fundamental dos tratamentos de erradicação do Helicobacter pylori. OBJETIVO: Avaliar a prevalência da resistência primária do H. pylori aos antibióticos em uma população urbana do Brasil. MÉTODOS: As cepas do H. pylori foram obtidas de pacientes submetidos a endoscopia digestiva para avaliação de sintomas dispépticos. Biopsias do antro, corpo e fundo gástrico foram realizadas para determinar a susceptibilidade das cepas do H. pylori aos antibióticos. A concentração inibitória mínima da furazolidona e do bismuto foram determinadas rotineira...</description>
            <author>Arquivos de Gastroenterologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469637</comments>
            <pubDate>Sun, 04 Dec 2011 09:45:50 +0100</pubDate>
            <guid isPermaLink="false">5469637</guid>        </item>
        <item>
            <title>Optimization Studies on Gastroretentive Floating System Using Response Surface Methodology.</title>
            <link>http://www.medworm.com/index.php?rid=5477482&amp;cid=c_31745_13_f&amp;fid=37302&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22135108%26dopt%3DAbstract</link>
            <description>In conclusion, it can be said that CCD is a valuable second-degree design to develop and optimize GFS of amoxicillin which in turn provides a basis to localize the drug release in the gastric region for effective treatment of H. pylori-mediated infection.
    PMID: 22135108 [PubMed - as supplied by publisher] (Source: AAPS PharmSciTech)</description>
            <author>AAPS PharmSciTech</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477482</comments>
            <pubDate>Fri, 02 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477482</guid>        </item>
        <item>
            <title>Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics</title>
            <link>http://www.medworm.com/index.php?rid=5470589&amp;cid=c_31745_33_f&amp;fid=33425&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F462t3760mk825u50%2F</link>
            <description>Conclusion Our findings confirm that despite the benefits of antenatal antibiotics, this treatment can increase the risk of antibiotic-resistant
 cases of LONI. National and international surveillance of LONI epidemiology is essential to assess benefits and potential
 negative consequences of perinatal antibiotic exposure.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00431-011-1639-7Authors
		Capucine Didier, Service de Pédiatrie 2, Hôpital de Hautepierre, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, FranceMarie-Pierre Streicher, Service de Pédiatrie, Centre Hospitalier de Haguenau, Haguenau, FranceDidier Chognot, Service de Pédiatrie, Hôpital le Parc, Centre Hospitalier de Colmar, Colmar, FranceRaphaèle Campagni, Service de Pédiatri...</description>
            <author>European Journal of Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470589</comments>
            <pubDate>Thu, 01 Dec 2011 19:29:38 +0100</pubDate>
            <guid isPermaLink="false">5470589</guid>        </item>
        <item>
            <title>Review article: rifabutin in the treatment of refractory Helicobacter pylori infection</title>
            <link>http://www.medworm.com/index.php?rid=5457885&amp;cid=c_31745_13_f&amp;fid=32539&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2036.2011.04937.x</link>
            <description>Conclusion  Rifabutin‐containing rescue therapy constitutes an encouraging strategy after multiple (usually three) previous eradication failures with key antibiotics such as amoxicillin, clarithromycin, metronidazole, tetracycline and levofloxacin. (Source: Alimentary Pharmacology and Therapeutics)</description>
            <author>Alimentary Pharmacology and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5457885</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5457885</guid>        </item>
        <item>
            <title>Response of feline eosinophilic plaques and lip ulcers to amoxicillin trihydrate-clavulanate potassium therapy: a randomized, double-blind placebo-controlled prospective study.</title>
            <link>http://www.medworm.com/index.php?rid=5474338&amp;cid=c_31745_80_f&amp;fid=37017&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22132827%26dopt%3DAbstract</link>
            <description>In this study, we evaluated the treatment of feline eosinophilic plaques and lip ulcers with amoxicillin trihydrate-potassium clavulanate (Clavamox(®) ; Pfizer Animal Health). Nineteen cats with clinical and cytological findings consistent with eosinophilic plaques and/or lip ulcers were enrolled. Lesions were photographed and their areas measured in square centimetres before and after 21 days of therapy with either flavoured amoxicillin-clavulanate suspension or flavoured placebo suspension. Sixteen cats completed the study, with nine plaque lesions (four treatment and five placebo) and eight lip ulcer lesions (four treatment and four placebo) included in the analysis. All lesions were shown to have infection, with bacterial phagocytosis present on cytological examination. Coagulase-po...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Veterinary Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5474338</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5474338</guid>        </item>
        <item>
            <title>Streptococcus agalactiae, an Emerging Pathogen for Cultured Ya‐Fish, Schizothorax prenanti, in China</title>
            <link>http://www.medworm.com/index.php?rid=5484137&amp;cid=c_31745_80_f&amp;fid=36980&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1865-1682.2011.01280.x</link>
            <description>In this study, four strains of a Gram‐positive, chain‐forming coccus were isolated from moribund cultured ya‐fish (S. prenanti). The coccoid microorganism was identified as S. agalactiae using a commercial streptococcal grouping kit and 16S rDNA sequencing analysis. Susceptibility of the isolates to 22 antibiotics was tested using the disc diffusion method. All isolates showed a similar antibiotic susceptibility, which were sensitive to amoxicillin, ciprofloxacin, lomefloxacin, chloramphenicol, rifampin, vancomycin, azithromycin, florfenicol, cefalexin, cefradine and deoxycycline and resistant to gentamicin, sinomin (SMZ/TMP), penicillin, tenemycin, fradiomycin and streptomycin. Furthermore, the virulence tests were conducted by intraperitoneal injection of the isolated strain GY10...</description>
            <author>Transboundary and Emerging Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5484137</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5484137</guid>        </item>
        <item>
            <title>Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).</title>
            <link>http://www.medworm.com/index.php?rid=5515769&amp;cid=c_31745_13_f&amp;fid=37253&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22173194%26dopt%3DAbstract</link>
            <description>Conclusions. Antimicrobial susceptibility data from the SMART-Spain study reinforce current therapeutic guidelines of intraabdominal infections that include ertapenem as the empirical choice for treatment. This is also supported by the high frequency of ESBL-producers in our geographic area.
    PMID: 22173194 [PubMed - in process] (Source: Revista Espanola de Quimioterapia)</description>
            <author>Revista Espanola de Quimioterapia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515769</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515769</guid>        </item>
        <item>
            <title>[Antimicrobial sensitivity of hippurate-negative Campylobacter and Helicobacter pullorum strains isolated from patients with diarrhea].</title>
            <link>http://www.medworm.com/index.php?rid=5515771&amp;cid=c_31745_13_f&amp;fid=37253&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22173192%26dopt%3DAbstract</link>
            <description>Authors: Bascuñana P, Pena I, Picazo JJ, Velasco AC
    Abstract
    C. jejuni as well as some hippurate-negative Campylobacter species and related diarrheagenic organisms, are the leading cause of gastroenteritis in our environment all throughout the year. The aim of the present study was to determine thesensitivity of hippurate-negative Campylobacter and Helicobacter pullorum strains isolated from the stools of patients with diarrhea. We tested 39 Campylobacter coli, two C. lari and five Helicobacter pullorum strains identified by mass spectrometry analysis. The sensitivity to amoxicillin-clavulanic acid, erytrhomycin, azithromycin, gentamicin, ciprofloxacin, levofloxacin, tetracycline, tigecycline and chloramphenicol was tested by E-test. Most hippurate-negative Campylobacter and H. pu...</description>
            <author>Revista Espanola de Quimioterapia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515771</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515771</guid>        </item>
        <item>
            <title>Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin.</title>
            <link>http://www.medworm.com/index.php?rid=5644665&amp;cid=c_31745_17_f&amp;fid=36151&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22287402%26dopt%3DAbstract</link>
            <description>Conclusion: It is observed that the efficacy of the triple therapy combination containing levofloxacin is not within acceptable limits for the first-line Helicobacter pylori eradication.
    PMID: 22287402 [PubMed - in process] (Source: The Turkish Journal of Gastroenterology)</description>
            <author>The Turkish Journal of Gastroenterology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644665</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644665</guid>        </item>
        <item>
            <title>Educational case series: β‐lactam allergy and cross‐reactivity</title>
            <link>http://www.medworm.com/index.php?rid=5456534&amp;cid=c_31745_3_f&amp;fid=33159&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1399-3038.2011.01204.x</link>
            <description>To cite this article: Atanasković‐Marković M. Educational case series: β‐lactam allergy and cross‐reactivity. Pediatr Allergy Immunol 2011: 22: 770–775.AbstractPenicillins and cephalosporins are the most widely used antibiotics for the treatment of common infections, and they are the two main classes of β‐lactams. On the basis of the time of appearance of the reaction after drug intake and for diagnostic purposes, hypersensitivity reactions to β‐lactams have been classified as immediate or non‐immediate. The diagnostic evaluation of allergic reactions to β‐lactams has changed over the last decade, for several reasons. In many countries, major and minor determinants for skin testing are not available. In immediate allergic reactions, the sensitivity of skin testing is ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Pediatric Allergy and Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5456534</comments>
            <pubDate>Wed, 30 Nov 2011 23:41:34 +0100</pubDate>
            <guid isPermaLink="false">5456534</guid>        </item>
        <item>
            <title>Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects.</title>
            <link>http://www.medworm.com/index.php?rid=5459444&amp;cid=c_31745_11_f&amp;fid=28257&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22126282%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Periodontal therapy improved GCF cytokine profiles by lowering IL-1β and increasing IL-10 levels. The reduction in GCF GM-CSF after therapy implicates this cytokine in the pathogenesis of GAgP. There was no difference between therapies in changes of GCF cytokines.
    PMID: 22126282 [PubMed - as supplied by publisher] (Source: Journal of Clinical Periodontology)</description>
            <author>Journal of Clinical Periodontology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5459444</comments>
            <pubDate>Wed, 30 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5459444</guid>        </item>
        <item>
            <title>Helicobacter pylori Eradication in Functional Dyspepsia: HEROES Trial [Original Investigation]</title>
            <link>http://www.medworm.com/index.php?rid=5452947&amp;cid=c_31745_49_f&amp;fid=28853&amp;url=http%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F171%2F21%2F1929%3Frss%3D1</link>
            <description>Conclusion&amp;nbsp; Helicobacter pylori eradication provided significant benefits to primary care patients with functional dyspepsia.
Trial Registration&amp;nbsp; clinicaltrials.gov Identifier: NCT00404534 (Source: Archives of Internal Medicine)</description>
            <author>Archives of Internal Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5452947</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5452947</guid>        </item>
        <item>
            <title>Growth-inhibiting effects of Paeonia lactiflora root steam distillate constituents and structurally related compounds on human intestinal bacteria</title>
            <link>http://www.medworm.com/index.php?rid=5454474&amp;cid=c_31745_77_f&amp;fid=39236&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm70831024n718871%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The growth-inhibiting activities of Paeonia lactiflora (Paeoniaceae) root steam distillate constituents and structurally related compounds against nine harmful intestinal bacteria
 and eight lactic acid-producing bacteria were compared with those of two antibiotics, amoxicillin and tetracycline. Thymol,
 α-terpinolene, (−)-perilla alcohol and (1R)-(−)-myrtenol exhibited high to extremely high levels of growth inhibition of all the harmful bacteria, whereas thymol and
 α-terpinolene (except for Lactobacillus casei ATCC 393) inhibited the growth of all the beneficial bacteria (MIC, both 0.08–0.62&amp;nbsp;mg&amp;nbsp;mL−1). Tetracycline and amoxicillin exhibited extremely high level of growth inhibition of all the test bacteria (MIC, &amp;lt;0.00002–0.001&amp;nbsp;mg&amp;nbsp;mL...</description>
            <author>World Journal of Microbiology and Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5454474</comments>
            <pubDate>Fri, 25 Nov 2011 17:57:22 +0100</pubDate>
            <guid isPermaLink="false">5454474</guid>        </item>
        <item>
            <title>A Blast from the Past</title>
            <link>http://www.medworm.com/index.php?rid=5442810&amp;cid=c_31745_22_f&amp;fid=34384&amp;url=http%3A%2F%2Fwww.amjmed.com%2Farticle%2FPIIS0002934311005791%2Fabstract%3Frss%3Dyes</link>
            <description>Common complaints tend to be explained by common conditions, but sometimes that assumption is wrong. A 56-year-old man presented with cough, skin lesions, and left knee pain. Five months earlier, he had developed a cough that occasionally produced blood-tinged sputum. A smoker, he was told he had bronchitis, for which he received courses of levofloxacin, inhaled bronchodilators, and inhaled corticosteroids; this was followed by a course of amoxicillin. There was no noticeable improvement, and 5 weeks prior to presentation at The University of Illinois at Chicago, his left knee became painful and swollen. At the same time, he developed skin lesions that a dermatologist diagnosed as acne; he was treated with doxycycline for 3 weeks. When his skin worsened to the point that he thought it emba...</description>
            <author>The American Journal of Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442810</comments>
            <pubDate>Fri, 25 Nov 2011 12:06:30 +0100</pubDate>
            <guid isPermaLink="false">5442810</guid>        </item>
        <item>
            <title>An audit of clinical outcome for patients with community-acquired pneumonia treated with combinations of benzylpenicillin, chloramphenicol and doxycycline: Category: Scientific free paper</title>
            <link>http://www.medworm.com/index.php?rid=5442426&amp;cid=c_31745_20_f&amp;fid=38514&amp;url=http%3A%2F%2Fwww.journalofinfection.com%2Farticle%2FPIIS0163445311002143%2Fabstract%3Frss%3Dyes</link>
            <description>An update to the British Thoracic Society (BTS) national guideline for the management of community-acquired pneumonia (CAP) was published in 2009. The BTS guideline recommends preferred treatment with amoxicillin for low severity CAP, a beta-lactam (amoxicillin or benzylpenicillin) with clarithromycin for moderate severity CAP and co-amoxiclav with clarithromycin for severe CAP. The BTS made a standard data collection template available to UK hospitals to audit adherence to selected elements of the CAP guideline. First-line empirical antibiotic treatment recommendations for CAP in our 1,000-bed university hospital differ from those of the BTS guideline in an effort to mitigate the risk of Clostridium difficile superinfection. This non-randomised prospective observational study was carried ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442426</comments>
            <pubDate>Fri, 25 Nov 2011 11:05:46 +0100</pubDate>
            <guid isPermaLink="false">5442426</guid>        </item>
        <item>
            <title>A pain in the neck: Category: Clinical lesson</title>
            <link>http://www.medworm.com/index.php?rid=5442477&amp;cid=c_31745_20_f&amp;fid=38514&amp;url=http%3A%2F%2Fwww.journalofinfection.com%2Farticle%2FPIIS0163445311002659%2Fabstract%3Frss%3Dyes</link>
            <description>A severely immunocompromised Zimbabwean man with advanced HIV disease diagnosed 10 years previously presented with a three week history of sore throat, dysphagia, right ear discharge and fever. He was not on anti-retroviral treatment at the time, having been previously unable to comply with numerous Highly Active Anti-Retroviral Therapy (HAART) regimens, and had a CD4 count of 5 cells/ml and HIV viral load of 946,106 copies/ml. His other active HIV related problems included recurrent peri-anal herpes, HIV dermopathy and recurrent folliculitis, chronic suppurative otitis media, co-infection with Hepatitis B, renal dysfunction, peripheral neuropathy and impotence. His most recent travel had been to Zimbabwe five years earlier. On examination he had a temperature of 38oC, a tender, enlarged r...</description>
            <author>Journal of Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442477</comments>
            <pubDate>Fri, 25 Nov 2011 11:05:46 +0100</pubDate>
            <guid isPermaLink="false">5442477</guid>        </item>
        <item>
            <title>Itching to know the diagnosis: Category: Lesson in Microbiology &amp; Infection Control</title>
            <link>http://www.medworm.com/index.php?rid=5442360&amp;cid=c_31745_20_f&amp;fid=38514&amp;url=http%3A%2F%2Fwww.journalofinfection.com%2Farticle%2FPIIS0163445311001484%2Fabstract%3Frss%3Dyes</link>
            <description>A normally healthy 22 year old male presented to our hospital with a two day history of unbearably itchy hands and feet. Although this was his main complaint, he had also noticed the development of a widespread rash over the last 24 hours and had been feverish with rigors overnight. He additionally complained of a mild sore throat, and of a chronic &quot;ingrown hair&quot; at the natal cleft which had become more painful recently. On examination, he had a 3cm wide pilonidal abscess. A macular blanching rash was present on the patient's hands, feet, forearms, and abdomen. Despite complaining of a sore throat, his throat looked normal. Observations taken in A&amp;E showed that he was pyrexial and tachycardic. At this point, his rash was thought to be viral in nature, but in view of his sepsis he was comme...</description>
            <author>Journal of Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442360</comments>
            <pubDate>Fri, 25 Nov 2011 11:05:45 +0100</pubDate>
            <guid isPermaLink="false">5442360</guid>        </item>
        <item>
            <title>Mecillinam as a potential therapy for lower urinary tract infections caused by organisms resistant to first line antibiotics: Category: Scientific free paper</title>
            <link>http://www.medworm.com/index.php?rid=5442364&amp;cid=c_31745_20_f&amp;fid=38514&amp;url=http%3A%2F%2Fwww.journalofinfection.com%2Farticle%2FPIIS0163445311001526%2Fabstract%3Frss%3Dyes</link>
            <description>Background: Significant numbers of urinary pathogens are now resistant to first line antibiotics such as trimethoprim and amoxicillin. Many second line antibiotics either have a broad spectrum of activity, carrying the risk of increasing antimicrobial resistance and Clostridium difficile infection (CDI), or are not available as oral formulations. Mecillinam is an orally administered beta-lactam antibiotic which has a low propensity for inducing CDI and, despite widespread use in Scandinavian countries for more than three decades, for which resistance has remained low. The aim of this study was to investigate the sensitivities of local urinary isolates to mecillinam, specifically those isolates resistant to first line antimicrobials. (Source: Journal of Infection)</description>
            <author>Journal of Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442364</comments>
            <pubDate>Fri, 25 Nov 2011 11:05:45 +0100</pubDate>
            <guid isPermaLink="false">5442364</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Lek Pharmaceuticals, Inc.]</title>
            <link>http://www.medworm.com/index.php?rid=5441407&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D56533</link>
            <description>Updated Date: Nov 23, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441407</comments>
            <pubDate>Wed, 23 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5441407</guid>        </item>
        <item>
            <title>Allopurinol/amoxicillin/clavulanic acid: Toxic epidermal necrolysis treated with ciclosporin: 3 case reports</title>
            <link>http://www.medworm.com/index.php?rid=5431892&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001378%2Fart00017</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431892</comments>
            <pubDate>Tue, 22 Nov 2011 06:51:47 +0100</pubDate>
            <guid isPermaLink="false">5431892</guid>        </item>
        <item>
            <title>Amoxicillin/clavulanic acid: Hepatotoxicity: case report</title>
            <link>http://www.medworm.com/index.php?rid=5431897&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001378%2Fart00022</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431897</comments>
            <pubDate>Tue, 22 Nov 2011 06:51:47 +0100</pubDate>
            <guid isPermaLink="false">5431897</guid>        </item>
        <item>
            <title>Role of gastritis pattern on Helicobacter pylori eradication</title>
            <link>http://www.medworm.com/index.php?rid=5441578&amp;cid=c_31745_14_f&amp;fid=35975&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmj23j0h056rq1q68%2F</link>
            <description>This study aimed to evaluate the role of different gastritis patterns on the efficacy of
 the currently suggested 14-day triple therapy regimen. One-hundred and seventeen, consecutive, non-ulcer dyspeptic patients,
 with H. pylori infection diagnosed at endoscopy, were enrolled. All patients received a 14-day, triple therapy with lansoprazole 30&amp;nbsp;mg,
 clarithromycin 500&amp;nbsp;mg and amoxicillin 1&amp;nbsp;g, all given twice daily. Bacterial eradication was assessed with 13C-urea breath test 4–6&amp;nbsp;weeks after completion of therapy. H. pylori infection was cured in 70.1% at ITT analysis and 83.7% at PP analysis. The eradication rate tended to be lower in patients
 with corpus-predominant gastritis as compared to those with antral-predominant gastritis at both ITT (66.1 vs 74.5%) and PP (...</description>
            <author>Internal and Emergency Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441578</comments>
            <pubDate>Mon, 21 Nov 2011 18:10:17 +0100</pubDate>
            <guid isPermaLink="false">5441578</guid>        </item>
        <item>
            <title>Lip Ulceration Associated with Intravenous Administration of Zoledronic Acid: Report of a Case</title>
            <link>http://www.medworm.com/index.php?rid=5443562&amp;cid=c_31745_32_f&amp;fid=35965&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F02r763p7lr873j33%2F</link>
            <description>This report,
 for the first time, describes the mucosal ulceration related to intravenous use of zoledronic acid (ZA). A 52-year-old female
 patient presented with painful ulcers on both cutaneous/mucosal surfaces of the lower lip and a 2-month history of osteonecrosis
 of the mandible beside the right lower canine. Her medical record included intravenous administration of ZA for 10&amp;nbsp;months
 for primary breast cancer metastatic to bone. Examination of the peripheral blood showed severe anemia and a slightly increased
 white blood cell count, due to urinary tract infection by E. coli, but no evidence of a viral infection. The treatment of anemia and E. coli infection did not improve the labial ulcers. Biopsy from the mucosal lesion revealed a non-specific ulceration with moderate
 infla...</description>
            <author>Head and Neck Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443562</comments>
            <pubDate>Mon, 21 Nov 2011 18:08:27 +0100</pubDate>
            <guid isPermaLink="false">5443562</guid>        </item>
        <item>
            <title>[Department of Error] Department of Error</title>
            <link>http://www.medworm.com/index.php?rid=5423436&amp;cid=c_31745_22_f&amp;fid=30418&amp;url=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2811%2961776-5%2Ffulltext%3Frss%3Dyes</link>
            <description>Malfertheiner P, Bazzoli F, Delchier JC, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet 2011;377: 905–13—In this Article (March 12), the fourth sentence of the third paragraph in the Procedures section (p 906) should have read: “In the 7-day standard regimen, one capsule of omeprazole, two of amoxicillin, and one of clarithromycin were taken twice daily (before morning and evening meals). (Source: LANCET)</description>
            <author>LANCET</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423436</comments>
            <pubDate>Sat, 19 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5423436</guid>        </item>
        <item>
            <title>[Articles] Community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Haripur district, Pakistan: a cluster randomised trial</title>
            <link>http://www.medworm.com/index.php?rid=5423440&amp;cid=c_31745_22_f&amp;fid=30418&amp;url=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2811%2961140-9%2Fabstract%3Frss%3Dyes</link>
            <description>The objective in this study was to assess whether community case management by lady health workers (LHWs) with oral amoxicillin in children with severe pneumonia was equivalent to current standard of care.MethodsIn Haripur district, Pakistan, 28 clusters were randomly assigned with stratification in a 1:1 ratio to intervention and control clusters by use of a computer-generated randomisation sequence. (Source: LANCET)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>LANCET</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423440</comments>
            <pubDate>Sat, 19 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5423440</guid>        </item>
        <item>
            <title>Clinical management of ESBL-producing Enterobacteriaceae: the insidious role of fluoroquinolones</title>
            <link>http://www.medworm.com/index.php?rid=5437768&amp;cid=c_31745_77_f&amp;fid=33419&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy3p6r058061t5073%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During a review of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in our Hospital, a huge number of inadequate antimicrobial therapies emerged. The aim of this study is to assess the factors
 related to such inadequacy. This retrospective analysis was performed on isolates reported by the microbiology laboratory.
 Medical records were analyzed to assess adequate treatment; inadequacy was evaluated as overall therapy, antibiotic choice,
 dosage and length of treatment. Linear regression and multivariate analysis were performed to assess any association. One
 hundred and fifty isolates were analyzed. They were more commonly isolated from urinary samples and from patients admitted
 to the Internal Medicine Department; E. coli was the most commonly isola...</description>
            <author>European Journal of Clinical Microbiology and Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5437768</comments>
            <pubDate>Fri, 18 Nov 2011 06:55:57 +0100</pubDate>
            <guid isPermaLink="false">5437768</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Teva Pharmaceuticals USA Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5422488&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D56197</link>
            <description>Updated Date: Nov 18, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422488</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5422488</guid>        </item>
        <item>
            <title>Effect of Pretreatment with Lactobacillus gasseri OLL2716 on First‐line Helicobacter pylori Eradication Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5422928&amp;cid=c_31745_17_f&amp;fid=30386&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1440-1746.2011.06985.x</link>
            <description>Conclusion: This study confirmed that the major cause of treatment failure is resistance to clarithromycin. A 4‐week treatment with L. gasseri‐containing yogurt improves the efficacy of triple therapy in patients with H. pylori infection. (Source: Journal of Gastroenterology and Hepatology)</description>
            <author>Journal of Gastroenterology and Hepatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422928</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5422928</guid>        </item>
        <item>
            <title>[Urinary tract infections: antibiotic resistance and clinical follow up.]</title>
            <link>http://www.medworm.com/index.php?rid=5448611&amp;cid=c_31745_33_f&amp;fid=36891&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22104020%26dopt%3DAbstract</link>
            <description>Authors: de Lucas Collantes C, Cela Alvargonzalez J, Angulo Chacón AM, García Ascaso M, Piñeiro Pérez R, Cilleruelo Ortega MJ, Sánchez Romero I
    Abstract
    The initial treatment of the urinary tract infections (UTI) is empirical and it is a priority to determine the antibiotic resistance of most common germs in a population. Furthermore, due to the suspicion of acute pyelonephritis the presence of renal scarring should be ruled out as this may lead to further complications. A retrospective longitudinal study was performed on all children under 14 years diagnosed with UTI from January 1 2009 to December 31 2009. The in vitro susceptibility to the most important urinary pathogens was analysed, along with the presence of scars, and a subsequent follow-up. The most frequently isolate...</description>
            <author>Anales de Pediatria</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5448611</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5448611</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMpowder, For Suspension [Teva Pharmaceuticals USA Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5422403&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D56112</link>
            <description>Updated Date: Nov 17, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422403</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5422403</guid>        </item>
        <item>
            <title>Amoxicillin: Cholestatic hepatitis: case report</title>
            <link>http://www.medworm.com/index.php?rid=5408464&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001377%2Fart00015</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408464</comments>
            <pubDate>Wed, 16 Nov 2011 21:59:42 +0100</pubDate>
            <guid isPermaLink="false">5408464</guid>        </item>
        <item>
            <title>Amoxicillin/ceftriaxone/lamotrigine: Drug hypersensitivity reactions in pediatric patients: 3 case reports</title>
            <link>http://www.medworm.com/index.php?rid=5408465&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001377%2Fart00016</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408465</comments>
            <pubDate>Wed, 16 Nov 2011 21:59:42 +0100</pubDate>
            <guid isPermaLink="false">5408465</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Chewable [Teva Pharmaceuticals USA Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5408945&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D55937</link>
            <description>Updated Date: Nov 16, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408945</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5408945</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMpowder, For Suspension [Teva Pharmaceuticals USA Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5408946&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D55938</link>
            <description>Updated Date: Nov 16, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408946</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5408946</guid>        </item>
        <item>
            <title>Presentation, antibiotic management and associated outcome in Polish adults presenting with acute cough/LRTI</title>
            <link>http://www.medworm.com/index.php?rid=5412022&amp;cid=c_31745_35_f&amp;fid=28826&amp;url=http%3A%2F%2Ffampra.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F28%2F6%2F608%3Frss%3D1</link>
            <description>Conclusions. Antibiotics continue to be frequently prescribed for acute cough/LRTI in Poland, and the decision to prescribe was strongly associated with clinicians&amp;rsquo; findings of abnormalities on auscultation and diagnosis of LRTI. Delayed prescribing was infrequent. Mucolytics were commonly prescribed despite evidence of no effect. (Source: Family Practice)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Family Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5412022</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5412022</guid>        </item>
        <item>
            <title>Characterization of the inhibitor-resistant SHV β-lactamase (SHV-107) in a clinical Klebsiella pneumoniae strain co-producing GES-7 enzyme.</title>
            <link>http://www.medworm.com/index.php?rid=5417808&amp;cid=c_31745_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083476%26dopt%3DAbstract</link>
            <description>Authors: Manageiro V, Ferreira E, Cougnoux A, Albuquerque L, Caniça M, Bonnet R
    Abstract
    The clinical K. pneumoniae INSRA6884 strain exhibited non-susceptibility to all penicillins tested (MICs of 64 to &amp;gt;2048 μg/ml). The MICs of penicillins were weakly reduced by clavulanate (from 2048 to 512 μg/ml), and tazobactam restored piperacillin susceptibility. Molecular characterization identified the genes bla(GES-7) and a new β-lactamase gene bla(SHV-107), which encoded an enzyme that differed from SHV-1 by the amino acid substitutions Leu35Gln and Thr235Ala. The SHV-107-producing E. coli strain exhibited only a β-lactam resistance phenotype with respect to amoxicillin, ticarcillin and amoxicillin/clavulanate combination. The kinetic parameters of the purified SHV-107 enzyme reve...</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5417808</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5417808</guid>        </item>
        <item>
            <title>Management of Recurrent Cutaneous Abscesses During Therapy With Infliximab.</title>
            <link>http://www.medworm.com/index.php?rid=5427160&amp;cid=c_31745_13_f&amp;fid=35408&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22088412%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: This case report describes a woman with psoriasis and psoriatic arthritis who developed MSSA skin abscesses after each of the first 3 infliximab infusions, which did not recur for the next 6 infusions after amoxicillin + clavulanic acid was added to her regimen, pre- and 4 days postinfusion. Adequately designed, placebo-controlled, double-blind trials are needed to determine whether such prophylactic antibiotic treatment is well tolerated or effective for this common complication of therapy with anti-TNF-α agents, when withdrawal of the drug is not advisable, as in this case.
    PMID: 22088412 [PubMed - as supplied by publisher] (Source: Clinical Therapeutics)</description>
            <author>Clinical Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5427160</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5427160</guid>        </item>
        <item>
            <title>Isolation of Bisgaardia hudsonensis from a seal bite</title>
            <link>http://www.medworm.com/index.php?rid=5598917&amp;cid=c_31745_20_f&amp;fid=38514&amp;url=http%3A%2F%2Fwww.journalofinfection.com%2Farticle%2FPIIS0163445311005548%2Fabstract%3Frss%3Dyes</link>
            <description>We read with interest the recent case report of Bisgaardia hudsonensis from a patient with an infected seal bite.  We notice with some concern that there was no mention of whether testing for Mycoplasma was attempted as Mycoplasma phocicerebrale is the most commonly isolated organism from “seal finger” or “speck finger”, an infection that can occur from handling seals or from infected bite wounds. Studies by our group on UK common and grey seals recovered M. phocicerebrale from various sites, including the teeth. Furthermore our studies also found M. phocicerebrale to be the most common organism isolated from infected bite wounds following aggressive interactions between seals. The GP in this case selected to use amoxicillin/clavulanic acid treatment and not tetracycline, the treat...</description>
            <author>Journal of Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598917</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5598917</guid>        </item>
        <item>
            <title>Prevalence, patterns of use, and socio-demographic factors of self medication with antibiotics in Yogyakarta City Indonesia: cross sectional population based survey</title>
            <link>http://www.medworm.com/index.php?rid=5402483&amp;cid=c_31745_39_f&amp;fid=37719&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2Fcontent%2F4%2F1%2F491</link>
            <description>This study investigated the period prevalence, patterns of use, and socio-demographic factors associated with self medication with antibiotics in Yogyakarta City Indonesia. This cross-sectional population-based survey used a pre-tested questionnaire which was self-administered to randomly selected respondents (over 18 years old) in Yogyakarta City Indonesia in 2010 (N=625). Descriptive statistics, chi-square and logistic regression were applied.A total of 559 questionnaires were analyzed (response rate = 90%). The period prevalence of self medication with antibiotics during the month prior to the study was 7.3 %. Amoxicillin was the most popular (77%) antibiotic for self medication besides ampicillin, fradiomycin-gramicidin, tetracycline, and ciprofloxacin to treat the following symptoms: ...</description>
            <author>BMC Research Notes</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5402483</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5402483</guid>        </item>
        <item>
            <title>Antibiotic Resistance of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections: an Exploratory Study in Palestine.</title>
            <link>http://www.medworm.com/index.php?rid=5427052&amp;cid=c_31745_13_f&amp;fid=38034&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082328%26dopt%3DAbstract</link>
            <description>Conclusion: E. coli was the most frequent bacterium in the studied sample and showed high resistance to first-line antibiotics. Our results highlight the need for developing local guidelines where elevated resistance to antibiotics should influence prescribing decisions.
    PMID: 22082328 [PubMed - as supplied by publisher] (Source: Current Clinical Pharmacology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Current Clinical Pharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5427052</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5427052</guid>        </item>
        <item>
            <title>Female Health Workers Treating Kids With Severe Pneumonia Minimizes Treatment Delays And Failures - Pakistan</title>
            <link>http://www.medworm.com/index.php?rid=5394150&amp;cid=c_31745_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FETaz-u9zwA4%2F237475.php</link>
            <description>In time for World Pneumonia Day on November 12, a global study published Online First in The Lancet reveals that using Lady Health Workers (LHWs) in Pakistan's community in order to treat people with severe pneumonia with amoxicillin reduces delays in treatment and failures compared with standard care.  The study was conducted in the Haripur district, northern Pakistan, by Dr Salim Sadruddin and his team in collaboration with Save the Children, USA, and worldwide... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394150</comments>
            <pubDate>Fri, 11 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5394150</guid>        </item>
        <item>
            <title>Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second‐line or Rescue Treatment of Helicobacter pylori Infection</title>
            <link>http://www.medworm.com/index.php?rid=5388358&amp;cid=c_31745_17_f&amp;fid=30385&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1523-5378.2011.00867.x</link>
            <description>Conclusion:  Second‐line/rescue H. pylori eradication therapy with esomeprazole, moxifloxacin, and amoxicillin is very effective and well tolerated. Fourteen days of treatment significantly increase the eradication rate but also the rate of adverse events. (Source: Helicobacter)</description>
            <author>Helicobacter</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388358</comments>
            <pubDate>Thu, 10 Nov 2011 10:20:41 +0100</pubDate>
            <guid isPermaLink="false">5388358</guid>        </item>
        <item>
            <title>The importance of patch tests in the differential diagnosis of adverse drug reactions</title>
            <link>http://www.medworm.com/index.php?rid=5386941&amp;cid=c_31745_12_f&amp;fid=37417&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0365-05962011000700004%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>We report the case of a 39-year-old woman diagnosed with systemic lupus erythematosus, who presented at the emergency clinic with exudative erythema multiforme which started 10 days after taking amoxicillin and clavulanic acid for tonsillitis together (almost simultaneously) with the pneumococcal vaccine. Rowell's syndrome was also considered to be a possibility. Skin patch tests were carried with the standard battery of patches (GPEDC) and the active ingredients of the suspected drugs (Chemotechnique ®), with readings at D2 and D3. The tests were positive for amoxicillin 10% pet (++), ampicillin 10% pet (+ +) and penicillin G potassium 10% pet (+). We accepted the diagnosis of erythema multiforme due to amoxicillin, confirmed by patch testing (Source: Anais Brasileiros de Dermatologia)</description>
            <author>Anais Brasileiros de Dermatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5386941</comments>
            <pubDate>Thu, 10 Nov 2011 07:13:02 +0100</pubDate>
            <guid isPermaLink="false">5386941</guid>        </item>
        <item>
            <title>Yersinia enterocolitica strains associated with human infections in Switzerland 2001–2010</title>
            <link>http://www.medworm.com/index.php?rid=5404964&amp;cid=c_31745_77_f&amp;fid=33419&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg2533m736732832h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Yersinia enterocolitica infections are common in humans. However, very scarce data are available on the different biotypes and virulence factors
 of human strains, which has proved to be problematic to assess the clinical significance of the isolated strains. In this
 study, the presence of the ail gene and distribution of different bio- and serotypes among human Y. enterocolitica strains and their possible relation to the genotype and antimicrobial resistance were studied. In total, 128 Y. enterocolitica strains isolated from human clinical samples in Switzerland during 2001–2010 were characterised. Most (75 out of 128) of
 the Y. enterocolitica strains belonged to biotypes 2, 3 or 4 and carried the ail gene. One of the 51 strains that belonged to biotype 1A was al...</description>
            <author>European Journal of Clinical Microbiology and Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5404964</comments>
            <pubDate>Thu, 10 Nov 2011 06:46:17 +0100</pubDate>
            <guid isPermaLink="false">5404964</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]</title>
            <link>http://www.medworm.com/index.php?rid=5401005&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D55547</link>
            <description>Updated Date: Nov 10, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5401005</comments>
            <pubDate>Thu, 10 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5401005</guid>        </item>
        <item>
            <title>A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5409375&amp;cid=c_31745_17_f&amp;fid=33349&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F255147306u060467%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In a large-scale nationwide study of use in clinical practice, RAC therapy was confirmed to be effective and safe.
 
 
 
	Content Type Journal ArticleCategory Original Article—Alimentary TractPages 1-8DOI 10.1007/s00535-011-0487-6Authors
		Toshio Fujioka, Department of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita 879-5593, JapanNobuo Aoyama, GI Endoscopy and IBD Center, Aoyama Clinic, Kobe, JapanKyoko Sakai, Center for Digestive and Liver Diseases, Nara City Hospital, Nara, JapanYoshiyuki Miwa, Miwa Clinic, Gifu, JapanMineo Kudo, Department of Gastroenterology, Sapporo Hokuyu Hospital, Sapporo, JapanJunichi Kawashima, Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, ...</description>
            <author>Journal of Gastroenterology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409375</comments>
            <pubDate>Tue, 08 Nov 2011 06:48:06 +0100</pubDate>
            <guid isPermaLink="false">5409375</guid>        </item>
        <item>
            <title>Randomised clinical trial: comparative study of 10‐day sequential therapy with 7‐day standard triple therapy for Helicobacter pylori infection in naïve patients</title>
            <link>http://www.medworm.com/index.php?rid=5387081&amp;cid=c_31745_13_f&amp;fid=32539&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2036.2011.04902.x</link>
            <description>Conclusions  Ten‐day sequential therapy is more effective and equally tolerated for eradication of H. pylori infection compared with standard triple therapy. Sequential therapy may have a role as first‐line treatment for H. pylori infection. (Source: Alimentary Pharmacology and Therapeutics)</description>
            <author>Alimentary Pharmacology and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5387081</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5387081</guid>        </item>
        <item>
            <title>Influences of two antibiotic contaminants on the production, release and toxicity of microcystins.</title>
            <link>http://www.medworm.com/index.php?rid=5409310&amp;cid=c_31745_55_f&amp;fid=35531&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22074855%26dopt%3DAbstract</link>
            <description>Authors: Liu Y, Gao B, Yue Q, Guan Y, Wang Y, Huang L
    Abstract
    The influences of spiramycin and amoxicillin on the algal growth, production and release of target microcystins (MCs), MC-LR, MC-RR and MC-YR, in Microcystis aeruginosa were investigated through the seven-day exposure test. Spiramycin were more toxic to M. aeruginosa than amoxicillin according to their 50 percent effective concentrations (EC(50)) in algal growth, which were 1.15 and 8.03μg/l, respectively. At environmentally relevant concentrations of 100ng/l-1μg/l, spiramycin reduced the total MC content per algal cell and inhibited the algal growth, while exposure to amoxicillin led to increases in the total MC content per algal cell and the percentage of extracellular MCs, without affecting the algal growth. Toxici...</description>
            <author>Ecotoxicology and Environmental Safety</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409310</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5409310</guid>        </item>
        <item>
            <title>Synergistic activity and mode of action of flavonoids isolated from smaller galangal and amoxicillin combinations against amoxicillin‐resistant Escherichia coli</title>
            <link>http://www.medworm.com/index.php?rid=5397539&amp;cid=c_31745_77_f&amp;fid=32055&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2672.2011.05190.x</link>
            <description>Conclusion:  These results indicated that these flavonoids have the potential to reverse bacterial resistance to amoxicillin in AREC and may operate via three mechanisms: inhibition of peptidoglycan and ribosome synthesis, alteration of outer membrane permeability and interaction with β‐lactamases.Significance and Impact of the Study:  These findings offer the potential to develop a new generation of phytopharmaceuticals to treat AREC. (Source: Journal of Applied Microbiology)</description>
            <author>Journal of Applied Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5397539</comments>
            <pubDate>Sun, 06 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5397539</guid>        </item>
        <item>
            <title>Empyema necessitatis due to Actinomyces israelii.</title>
            <link>http://www.medworm.com/index.php?rid=5430965&amp;cid=c_31745_40_f&amp;fid=36889&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22071386%26dopt%3DAbstract</link>
            <description>Authors: Gupta A, Lodato RF
    Abstract
    A 20-year-old male presented with a one month history of a tender mass in the lower left chest wall. Chest computed tomography (Panel A) showed fluid collection in the left pleural space (black arrow) extending into the extra-thoracic tissue (solid white arrow), consistent with empyema necessitatis. Heterogeneous foci were seen in the spleen suggestive of splenic abscesses (broken white arrow). Empyema necessitatis is a pyothorax with the pus eroding through the chest wall; eventually it may drain spontaneously through the skin. Grocott's methenamine silver (GMS) stain and cultures of the tissue revealed filamentous organisms (red arrow in Panel B) diagnostic of actinomycosis. The abscess was resected and the patient was treated successfully wit...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>American Journal of Respiratory and Critical Care Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5430965</comments>
            <pubDate>Thu, 03 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5430965</guid>        </item>
        <item>
            <title>Antibiotic resistant bacteria/genes dissemination in lacustrine sediments highly increased following cultural eutrophication of Lake Geneva (Switzerland).</title>
            <link>http://www.medworm.com/index.php?rid=5377300&amp;cid=c_31745_59_f&amp;fid=34409&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22051343%26dopt%3DAbstract</link>
            <description>This study investigates faecal indicator bacteria (FIB), multiple antibiotic resistant (MAR), and antibiotic resistance genes (ARGs), of sediment profiles from different parts of Lake Geneva (Switzerland) over the last decades. MARs consist to expose culturable Escherichia coli (EC) and Enterococcus (ENT) to mixed five antibiotics including Ampicillin, Tetracycline, Amoxicillin, Chloramphenicol and Erythromycin. Culture-independent is performed to assess the distribution of ARGs responsible for, β-lactams (blaTEM; Amoxicillin/Ampicillin), Streptomycin/Spectinomycin (aadA), Tetracycline (tet) Chloramphenicol (cmlA) and Vancomycin (van). Bacterial cultures reveal that in the sediments deposited following eutrophication of Lake Geneva in the 1970s, the percentage of MARs to five antibiotics ...</description>
            <author>Chemosphere</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5377300</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5377300</guid>        </item>
        <item>
            <title>Treatment of Streptococcal Pharyngitis with Once-Daily Amoxicillin versus Intramuscular Benzathine Penicillin G in Low-Resource Settings: A Randomized Control Trial: Rimoin AW, Hoff NA, Fischer Walker CL, et al. Clin Pediatr 2011;50:535–42.</title>
            <link>http://www.medworm.com/index.php?rid=5387963&amp;cid=c_31745_14_f&amp;fid=38509&amp;url=http%3A%2F%2Fwww.jem-journal.com%2Farticle%2FPIIS0736467911011292%2Fabstract%3Frss%3Dyes</link>
            <description>In this study, when patients were compliant with either treatment eradication, success rates were equivalent. However, in Egypt, where compliance with the 10-day oral amoxicillin treatment was a major issue, the IM BPG treatment was superior in successful treatment of GAS pharyngitis. (Source: The Journal of Emergency Medicine)</description>
            <author>The Journal of Emergency Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5387963</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5387963</guid>        </item>
        <item>
            <title>A Challenging Case: Symmetrical Drug Related Intertriginous and Flexural Exanthem, Fixed Drug Eruption, or Both?</title>
            <link>http://www.medworm.com/index.php?rid=5408131&amp;cid=c_31745_12_f&amp;fid=31727&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-1470.2011.01656.x</link>
            <description>Abstract:  We herein report a 12‐year‐old boy with amoxicillin‐induced, recurrent, site‐specific, symmetrical, sharply demarcated reddish plaques on the buttocks and the major flexural and intertriginous areas. The lesions resolved with topical corticosteroids, leaving hyperpigmentation. Histopathology showed nonspecific features of inflammation and dermal melanophages. Amoxicillin was the probable inducer based on oral provocation test with Amoksina® tablet, however patch testing with amoxicillin on previously affected and unaffected skin remained negative. The diagnosis was challenging because of the overlapping features of symmetrical drug‐related intertriginous and flexural exanthema and fixed drug eruption. This one represents a unique and challenging one with overlapping...</description>
            <author>Pediatric Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408131</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5408131</guid>        </item>
        <item>
            <title>Update on acute otitis media in children younger than 2 years of age.</title>
            <link>http://www.medworm.com/index.php?rid=5430295&amp;cid=c_31745_35_f&amp;fid=37737&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22084458%26dopt%3DAbstract</link>
            <description>Authors: McWilliams CJ, Goldman RD
    Abstract
    Question As concern about antimicrobial resistance grows, I am aware of the need to reduce unnecessary antibiotic treatment; however, in my practice I see many children with acute otitis media (AOM) and this is the most common reason I prescribe antibiotics. Most of these children are young and otherwise healthy, and I am uncertain about when to prescribe antibiotics and when to endorse &quot;watchful waiting.&quot; Which children will benefit from antibiotic treatment? Answer Current Canadian guidelines recommend all children younger than 2 years of age with otalgia due to AOM and fever greater than 39°C be considered for treatment with amoxicillin. Watchful waiting is indicated only for children older than 6 months with mild-to-moderate AOM. Rec...</description>
            <author>Canadian Family Physician Medecin de Famille Canadien</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5430295</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5430295</guid>        </item>
        <item>
            <title>Antimicrobial Drug Resistance in Corynebacterium diphtheriae mitis.</title>
            <link>http://www.medworm.com/index.php?rid=5447685&amp;cid=c_31745_20_f&amp;fid=33088&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22099107%26dopt%3DAbstract</link>
            <description>Authors: Barraud O, Badell E, Denis F, Guiso N, Ploy MC
    Abstract
    To the Editor: Corynebacterium diphtheriae is the agent of pharyngeal and cutaneous diphtheria. We did a retrospective analysis of the antimicrobial drug susceptibilities of 46 C. diphtheriae isolates sent during 1993 through 2010 to the French National Reference Centre of Toxigenic Corynebacteria. The isolates came from metropolitan France and French overseas departments and territories. Only 1 isolate, C. diphtheriae biovar mitis, FRC24, expressed the following antimicrobial drug susceptibility profile: susceptible to penicillin, amoxicillin, ciprofloxacin, clindamycin, erythromycin, gentamicin, imipenem, kanamycin, rifampin, tetracycline, and vancomycin and resistant at an uncommonly high level to trimethoprim, sul...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Emerging Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5447685</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5447685</guid>        </item>
        <item>
            <title>Differences in Evolution of Children With Non-severe Acute Lower Respiratory Tract Infection With and Without Radiographically Diagnosed Pneumonia.</title>
            <link>http://www.medworm.com/index.php?rid=5406236&amp;cid=c_31745_33_f&amp;fid=32765&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22080618%26dopt%3DAbstract</link>
            <description>CONCLUSION: Persistence of fever or tachypnea up to the second day of amoxicillin treatment is predictive of radiographically diagnosed pneumonia among children with non-severe lower respiratory tract diseases.
    PMID: 22080618 [PubMed - as supplied by publisher] (Source: Indian Pediatrics)</description>
            <author>Indian Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5406236</comments>
            <pubDate>Sun, 30 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5406236</guid>        </item>
        <item>
            <title>Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis</title>
            <link>http://www.medworm.com/index.php?rid=5371476&amp;cid=c_31745_47_f&amp;fid=33304&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F836p0m650w3135pn%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The administration of ceftriaxone is known to be associated with biliary pseudolithiasis, although the development of urolithiasis
 has only rarely been reported. We treated a young male with bacterial meningitis complicated by urinary precipitates composed
 of ceftriaxone–calcium salt, which prompted us to study whether ceftriaxone administration predisposes children to the formation
 of urinary precipitates. The case–control study reported here included 83 children with bacterial pneumonia aged from 3&amp;nbsp;months
 to 8.9&amp;nbsp;years. The children were divided into one group of 43 children who received ceftriaxone (group A) and a second group
 of 40 children who received amoxicillin (group B). Paired samples of serum and urine before and after treatment were obtaine...</description>
            <author>Pediatric Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371476</comments>
            <pubDate>Fri, 28 Oct 2011 17:14:11 +0100</pubDate>
            <guid isPermaLink="false">5371476</guid>        </item>
        <item>
            <title>Genotyping of Haemophilus influenzae type b in pre-vaccination era</title>
            <link>http://www.medworm.com/index.php?rid=5362799&amp;cid=c_31745_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft2k3785w527r4t50%2F</link>
            <description>This study was conducted between January
 2008 and August 2011 as part of a birth cohort study in Sado Island, Japan, to elucidate the prevalence of Hib and its clones
 in a specific region. Nasopharyngeal cultures were obtained from 349 subjects at 4-, 7-, 10-, 18-, and 36-month health checkups
 and analyzed for H. influenzae. The Hib and nontypeable H. influenzae detection rates ranged from 0 to 1.5% (12 isolates) and from 7.9 to 32.9%, respectively. Twelve pediatric patients diagnosed
 with invasive or non-invasive Hib infections during the study period were also enrolled. The Hib isolates were analyzed for
 carriage of the beta-lactamase gene and ftsI mutations, and multilocus sequence type (MLST, ST type). Of the 24 Hib isolates, 18 (75%) were ST54, 5 (21%) were ST190,
 and 1 isolate ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362799</comments>
            <pubDate>Fri, 28 Oct 2011 17:11:16 +0100</pubDate>
            <guid isPermaLink="false">5362799</guid>        </item>
        <item>
            <title>Attenuated total reflectance with Fourier transform infrared spectroscopy (ATR/FTIR) and different PLS Algorithms for simultaneous determination of clavulanic acid and amoxicillin in powder pharmaceutical formulation</title>
            <link>http://www.medworm.com/index.php?rid=5354811&amp;cid=c_31745_59_f&amp;fid=37487&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0103-50532011001000011%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>A method for simultaneous determination of clavulanic acid (CA) and amoxicillin (AMO) was developed using Fourier transform mid infrared technique coupled with attenuated total reflectance (ATR/FTIR) accessory. 27 samples were used as calibration set and 8 samples were used for prediction set. Calibration models were developed using partial least squares (PLS), interval PLS (iPLS), synergy PLS (siPLS) and backward PLS (biPLS). Multiplicative scatter correction and the mean centering were used and produced the best models. Relative standard error of prediction (RSEP) of 3.8% for CA and 5.1% for AMO were obtained using biPLS algorithm for ATR/FTIR data. Results obtained by the proposed methodology were compared with those using high performance liquid chromatography (HPLC) and no significant...</description>
            <author>Journal of the Brazilian Chemical Society</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5354811</comments>
            <pubDate>Thu, 27 Oct 2011 23:00:39 +0100</pubDate>
            <guid isPermaLink="false">5354811</guid>        </item>
        <item>
            <title>Amoxicillin/clavulanic acid: Acute generalised exanthematous pustulosis: case report</title>
            <link>http://www.medworm.com/index.php?rid=5347747&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001374%2Fart00015</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5347747</comments>
            <pubDate>Wed, 26 Oct 2011 13:05:17 +0100</pubDate>
            <guid isPermaLink="false">5347747</guid>        </item>
        <item>
            <title>Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens</title>
            <link>http://www.medworm.com/index.php?rid=5349198&amp;cid=c_31745_20_f&amp;fid=37207&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1471-2334%2F11%2F286</link>
            <description>Conclusions:
The only regimens to achieve high CFR against all three pathogen populations in both scenarios were gatifloxacin 400mg QD, moxifloxacin 400mg QD, and amoxicillin-clavulanate 500mg TID. These data suggest the need for reconsideration of empiric antibiotic regimen selection among adult patients with RTIs in the Sao Paulo area. Additionally, this type of study could be used to optimize prescribing patterns in specific regions in light of emerging resistance. (Source: BMC Infectious Diseases)</description>
            <author>BMC Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349198</comments>
            <pubDate>Tue, 25 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5349198</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMpowder, For Suspension AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Chewable [Sandoz Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5347881&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D54348</link>
            <description>Updated Date: Oct 24, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5347881</comments>
            <pubDate>Mon, 24 Oct 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5347881</guid>        </item>
        <item>
            <title>Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough</title>
            <link>http://www.medworm.com/index.php?rid=5336016&amp;cid=c_31745_13_f&amp;fid=32539&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2036.2011.04887.x</link>
            <description>Conclusion  Although a decrease in the H. pylori eradication rate after triple therapy has been suggested in recent years, cure rates with this regimen did not change in Spain between 1997 and 2008. However, this by no means indicates that the efficacy of standard triple therapy in Spain is acceptable, as it has been calculated to be around only 80%. Therefore, it is evident that new strategies to improve first‐line treatment are urgently needed. (Source: Alimentary Pharmacology and Therapeutics)</description>
            <author>Alimentary Pharmacology and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336016</comments>
            <pubDate>Sat, 22 Oct 2011 05:34:27 +0100</pubDate>
            <guid isPermaLink="false">5336016</guid>        </item>
        <item>
            <title>Retrospective case series analysis of penicillin allergy testing in a UK specialist regional allergy clinic</title>
            <link>http://www.medworm.com/index.php?rid=5338813&amp;cid=c_31745_32_f&amp;fid=28429&amp;url=http%3A%2F%2Fjcp.bmj.com%2Fcgi%2Fcontent%2Fshort%2F64%2F11%2F1014%3Frss%3D1</link>
            <description>Conclusion
The new PPL and MDM determinants offer enhanced sensitivity when evaluating &amp;beta;-lactam hypersensitivity; however, there are limitations to the current testing regimens. The UK would benefit from local guidelines, which incorporate the new reagents and acknowledge the high amoxicillin prescription rate and the relatively lower specialist-to-patient ratio in this country. (Source: Journal of Clinical Pathology)</description>
            <author>Journal of Clinical Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338813</comments>
            <pubDate>Sat, 22 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5338813</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMpowder, For Suspension [Dr Reddys Laboratories Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5336368&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D54134</link>
            <description>Updated Date: Oct 20, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336368</comments>
            <pubDate>Thu, 20 Oct 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5336368</guid>        </item>
        <item>
            <title>AUGMENTIN (Amoxicillin And Clavulanate Potassium) Tablet, Film Coated AUGMENTIN (Amoxicillin And Clavulanate Potassium) Tablet [Dr Reddys Laboratories Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5336372&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D54139</link>
            <description>Updated Date: Oct 20, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336372</comments>
            <pubDate>Thu, 20 Oct 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5336372</guid>        </item>
        <item>
            <title>AUGMENTIN (Amoxicillin And Clavulanate Potassium) Powder, For Suspension [Dr Reddys Laboratories Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5336398&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D54165</link>
            <description>Updated Date: Oct 20, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336398</comments>
            <pubDate>Thu, 20 Oct 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5336398</guid>        </item>
        <item>
            <title>AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Film Coated [Dr Reddys Laboratories Inc]</title>
            <link>http://www.medworm.com/index.php?rid=5336401&amp;cid=c_31745_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D54168</link>
            <description>Updated Date: Oct 20, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336401</comments>
            <pubDate>Thu, 20 Oct 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5336401</guid>        </item>
        <item>
            <title>Degradation of amoxicillin in aqueous solution using sulphate radicals under ultrasound irradiation.</title>
            <link>http://www.medworm.com/index.php?rid=5410961&amp;cid=c_31745_59_f&amp;fid=36214&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22079807%26dopt%3DAbstract</link>
            <description>Authors: Su S, Guo W, Yi C, Leng Y, Ma Z
    Abstract
    Degradation of the antibiotics amoxicillin in aqueous solution using sulphate radicals under ultrasound irradiation was investigated. The preliminary studies of optimal degradation methodology were conducted with only oxone (2KHSO(5)·KHSO(4)·K(2)SO(4)), cobalt activated oxone (oxone/Co(2+)), oxone+ultrasonication (oxone/US) and cobalt activated oxone+ultrasonication (oxone/Co(2+)/US). The chemical oxygen demand (COD) removal efficiency were in the order of oxone&amp;lt;oxone/Co(2+)&amp;lt;oxone/US&amp;lt;oxone/Co(2+)/US for the amoxicillin solution. The variables considered for the effect of degradation were the temperature, the power of ultrasound, the concentration of oxone, as well as catalyst and the initial amoxicillin concentration. Mor...</description>
            <author>Ultrasonics Sonochemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410961</comments>
            <pubDate>Thu, 20 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5410961</guid>        </item>
        <item>
            <title>Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication.</title>
            <link>http://www.medworm.com/index.php?rid=5334420&amp;cid=c_31745_28_f&amp;fid=37639&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22004585%26dopt%3DAbstract</link>
            <description>Authors: Xia W, Zhang X, Wang J, Sun C, Wu L
    Abstract
    In the present study, we investigated the prevalence of anaemia and Fe deficiency anaemia (IDA) and explored the relationship between Helicobacter pylori infection and IDA in adolescent girls. A total of 1037 adolescent girls from Suihua, China were enrolled. Hb, serum ferritin (SF), serum transferrin receptor (sTfR) and serum IgG antibodies to H. pylori were measured. Participants with IDA and co-existing H. pylori infection (n 80) who had an intake of &amp;gt;25 mg/d of Fe were assigned randomly to the intervention and control groups. Patients in the intervention group were administered a 12-week course of oral EDTA-Na-Fe (60 mg Fe/dose, three times a week) and a 2-week course of colloidal bismuth subcitrate, amoxicillin and met...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>The British Journal of Nutrition</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5334420</comments>
            <pubDate>Tue, 18 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5334420</guid>        </item>
        <item>
            <title>A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws</title>
            <link>http://www.medworm.com/index.php?rid=5422831&amp;cid=c_31745_16_f&amp;fid=36644&amp;url=http%3A%2F%2Fwww.ooooe.net%2Farticle%2FPIIS1079210411004446%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This conservative protocol seems to provide successful treatment in the vast majority of patients. (Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics)</description>
            <author>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422831</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5422831</guid>        </item>
        <item>
            <title>Impact of implementing French antibiotic guidelines for acute respiratory-tract infections in a paediatric emergency department, 2005–2009</title>
            <link>http://www.medworm.com/index.php?rid=5331391&amp;cid=c_31745_77_f&amp;fid=33419&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv5440lr5k7762787%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Acute respiratory tract infections (ARTIs) are the main reason for antibiotic prescription in children. In 2005, the French
 Drug Agency published guidelines to minimise inappropriate use of antibiotics for ARTI. The purpose of this study was to assess
 the impact of implementing these guidelines in a paediatric emergency department. We retrospectively analysed data collected
 prospectively in a French paediatric emergency department from November 2005 (date of guideline implementation) to October
 2009. For each child diagnosed with ARTI, we collected age, diagnosis, and prescribed antibiotics. We computed antibiotic
 prescription rates in the study population. During the study period, 53,055 children were diagnosed with ARTI and 59% of the
 22,198 antibiotic prescript...</description>
            <author>European Journal of Clinical Microbiology and Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5331391</comments>
            <pubDate>Sat, 15 Oct 2011 15:45:01 +0100</pubDate>
            <guid isPermaLink="false">5331391</guid>        </item>
        <item>
            <title>Does the Use of Prophylactic Antibiotics Decrease Implant Failure?</title>
            <link>http://www.medworm.com/index.php?rid=5305068&amp;cid=c_31745_16_f&amp;fid=38628&amp;url=http%3A%2F%2Fwww.oralmaxsurgery.theclinics.com%2Farticle%2FPIIS1042369911001464%2Fabstract%3Frss%3Dyes</link>
            <description>The use of prophylactic antibiotics in implant dentistry is controversial. Given the known risks of antibiotic treatment and lack of consensus on using antibiotics at the time of implant insertion, the purpose of this article was to review available studies on use of perioperative prophylactic antibiotics at the time of implant placement and to provide evidence-based recommendations for antibiotic use. The reviewed studies suggest that a single preoperative dose of 2 g amoxicillin 1 hour before implant placement or 1 g amoxicillin 1 hour preoperatively and 500 mg 4 times daily 2 days postoperatively can reduce the rate of implant failure. (Source: Oral and Maxillofacial Surgery Clinics)</description>
            <author>Oral and Maxillofacial Surgery Clinics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305068</comments>
            <pubDate>Wed, 12 Oct 2011 07:56:23 +0100</pubDate>
            <guid isPermaLink="false">5305068</guid>        </item>
        <item>
            <title>Amoxicillin/clavulanic acid/ceftriaxone: Kounis syndrome: 2 case reports</title>
            <link>http://www.medworm.com/index.php?rid=5304646&amp;cid=c_31745_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001372%2Fart00017</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304646</comments>
            <pubDate>Wed, 12 Oct 2011 06:03:59 +0100</pubDate>
            <guid isPermaLink="false">5304646</guid>        </item>
        <item>
            <title>A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections</title>
            <link>http://www.medworm.com/index.php?rid=5311501&amp;cid=c_31745_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F66%2F11%2F2632%3Frss%3D1</link>
            <description>Conclusions
Once-daily iv/oral moxifloxacin monotherapy was clinically and bacteriologically non-inferior to iv TZP thrice daily followed by oral AMC twice daily in patients with cSSSIs. (Source: Journal of Antimicrobial Chemotherapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5311501</comments>
            <pubDate>Wed, 12 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5311501</guid>        </item>
        <item>
            <title>Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).</title>
            <link>http://www.medworm.com/index.php?rid=5302575&amp;cid=c_31745_22_f&amp;fid=38107&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21975746%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Generally, fluoroquinolones performed well in treating typhoid, and maybe superior to alternatives in some settings. However, we were unable to draw firm general conclusions on comparative contemporary effectiveness given that resistance changes over time, and many studies were small. Policy makers and clinicians need to consider local resistance patterns in choosing a fluoroquinolone or alternative.There is some evidence that the newest fluoroquinolone, gatifloxacin, remains effective in some regions where resistance to older fluoroquinolones has developed. However, the different fluoroquinolones have not been compared directly in trials in these settings.
    PMID: 21975746 [PubMed - in process] (Source: Cochrane Database of Systematic Reviews)</description>
            <author>Cochrane Database of Systematic Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5302575</comments>
            <pubDate>Tue, 11 Oct 2011 01:20:04 +0100</pubDate>
            <guid isPermaLink="false">5302575</guid>        </item>
        <item>
            <title>Resistance gene transfer during treatments of experimental avian colibacillosis.</title>
            <link>http://www.medworm.com/index.php?rid=5311661&amp;cid=c_31745_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21986830%26dopt%3DAbstract</link>
            <description>In conclusion, this study clearly illustrates how, in E. coli, &quot;old&quot; antimicrobials may co-select antimicrobial resistance to recent and critical molecules.
    PMID: 21986830 [PubMed - as supplied by publisher] (Source: Antimicrobial Agents and Chemotherapy)</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5311661</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5311661</guid>        </item>
        <item>
            <title>Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen, Streptococcus suis.</title>
            <link>http://www.medworm.com/index.php?rid=5378984&amp;cid=c_31745_77_f&amp;fid=37539&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21984241%26dopt%3DAbstract</link>
            <description>Authors: Meng X, Shi Y, Ji W, Meng X, Zhang J, Wang H, Lu C, Sun J, Yan Y
    Abstract
    Bacterial biofilms are crucial to the pathogenesis of many important infections and are difficult to eradicate. Streptococcus suis is an important pathogen of pigs and here the biofilm forming ability of 32 strains of this species was determined. Significant biofilms were completely formed by 10 of the strains after 60 hours incubation, with exopolysaccharide production in the biofilm significantly higher than that in the corresponding planktonic cultures. Streptococcus suis strain SS2-4 formed a dense biofilm as revealed by scanning electron microscopy and in this state exhibited increased resistance to a number of antibiotics (ampicillin, amoxicillin, ciprofloxacin, kanamycin and rifampicin) compar...</description>
            <author>Applied and Environmental Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5378984</comments>
            <pubDate>Fri, 07 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5378984</guid>        </item>
        <item>
            <title>Facile one-pot synthesis of gold nanoparticles and their sensing protocol</title>
            <link>http://www.medworm.com/index.php?rid=5280789&amp;cid=c_31745_59_f&amp;fid=33798&amp;url=http%3A%2F%2Ffeeds.rsc.org%2F%7Er%2Frss%2FCC%2F%7E3%2F5BBweGnKYc4%2FC1CC15154A</link>
            <description>Chem. Commun., 2011, Advance ArticleDOI: 10.1039/C1CC15154A, CommunicationAbdul Hameed, Nazar Ul Islam, Muhammad Raza Shah, Shamsa KanwalBiologically active semi-synthetic drug i.e. amoxicillin has been introduced for the first time for rapid synthesis of colloidal gold nanoparticles. Fluorescence quenching of Au-NPs enables Cu2+ sensing at nano scale levels.To cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC - Chem. Commun. latest articles)</description>
            <author>RSC - Chem. Commun. latest articles</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5280789</comments>
            <pubDate>Tue, 04 Oct 2011 05:44:37 +0100</pubDate>
            <guid isPermaLink="false">5280789</guid>        </item>
        <item>
            <title>[Study of nasopharyngeal carriage of Streptococcus pneumoniae and its antibiotics resistance in healthy children aged less than 2years in the Marrakech region (Morocco).]</title>
            <link>http://www.medworm.com/index.php?rid=5303362&amp;cid=c_31745_33_f&amp;fid=37543&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21978670%26dopt%3DAbstract</link>
            <description>CONCLUSION: These data show the frequency and the risk factors on nasopharyngeal carriage, and report the status of penicillin resistance of strains carrying children less than 2years of age in the Marrakech region. The fluctuation of circulating serotypes at the national level underscores the importance of epidemiological surveillance carried out before the introduction of the heptavalent vaccine in Morocco.
    PMID: 21978670 [PubMed - as supplied by publisher] (Source: Archives de Pediatrie)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Archives de Pediatrie</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5303362</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5303362</guid>        </item>
        <item>
            <title>Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models</title>
            <link>http://www.medworm.com/index.php?rid=5282022&amp;cid=c_31745_76_f&amp;fid=33690&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fsim.4390</link>
            <description>Bioequivalence or interaction trials are commonly studied in crossover design and can be analysed by nonlinear mixed effects models as an alternative to noncompartmental approach. We propose an extension of the population Fisher information matrix in nonlinear mixed effects models to design crossover pharmacokinetic trials, using a linearisation of the model around the random effect expectation, including within‐subject variability and discrete covariates fixed or changing between periods. We use the expected standard errors of treatment effect to compute the power for the Wald test of comparison or equivalence and the number of subjects needed for a given power. We perform various simulations mimicking crossover two‐period trials to show the relevance of these developments. We then ap...</description>
            <author>Statistics in Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5282022</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5282022</guid>        </item>
        <item>
            <title>Is amoxicillin plus clavulanic acid non-inferior to appendicectomy for the treatment of uncomplicated acute appendicitis?</title>
            <link>http://www.medworm.com/index.php?rid=5286252&amp;cid=c_31745_14_f&amp;fid=35975&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3439085682j202j7%2F</link>
            <description>Content Type Journal ArticleCategory CE - THE CUTTING EDGE: RESEARCH UPDATEPages 1-2DOI 10.1007/s11739-011-0694-4Authors
		Francesco Casella, Medicina Interna III, Dipartimento di Medicina, Ospedale “L. Sacco”, Università degli Studi di Milano, Milan, ItalyGiovanni Casazza, Dipartimento di Scienze Cliniche “L. Sacco”, Università degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, ItalyGruppo di Autoformazione Metodologica (GrAM)
	

	
		Journal Internal and Emergency MedicineOnline ISSN 1970-9366Print ISSN 1828-0447 (Source: Internal and Emergency Medicine)</description>
            <author>Internal and Emergency Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286252</comments>
            <pubDate>Sun, 02 Oct 2011 05:46:42 +0100</pubDate>
            <guid isPermaLink="false">5286252</guid>        </item>
        <item>
            <title>[Pyelonephritis table during the pregnancy: Think of the listeriosis].</title>
            <link>http://www.medworm.com/index.php?rid=5285776&amp;cid=c_31745_29_f&amp;fid=36722&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21396789%26dopt%3DAbstract</link>
            <description>We report a case of atypical listeriosis simulating pyelonephritis, in a pregnant woman who presented at 25 weeks gestation a left renal colic, operating in a febrile context; it was treated as urinary tract infection with gentamicin and ceftriaxon. The evolution was marked by the exacerbation of symptoms followed by in utero foetal death. Blood culture was performed in post abortion; the diagnosis was retained after bacteriological examination of the placenta. This observation suggested evoking listeriosis in any case of unexplained fever during pregnancy, even with clinical signs suggestive of pyelonephritis, and not delay making blood cultures and prescribing antibiotics in general an amoxicillin.
    PMID: 21396789 [PubMed - in process] (Source: Journal de Gynecologie, Obstetrique et B...</description>
            <author>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5285776</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5285776</guid>        </item>
        <item>
            <title>Effectiveness of systemic antibiotic prophylaxis with amoxicillin in preventing postoperative infectious complications after impacted third molar surgery: a systematic review of randomized clinical trials</title>
            <link>http://www.medworm.com/index.php?rid=5315418&amp;cid=c_31745_16_f&amp;fid=35742&amp;url=http%3A%2F%2Fwww.ijoms.com%2Farticle%2FPIIS0901502711003377%2Fabstract%3Frss%3Dyes</link>
            <description>Purpose: The removal of third molars is one of the most common procedures in oral surgery and inflammatory and infectious complications have been vastly documented in the literature. (Source: International Journal of Oral and Maxillofacial Surgery)</description>
            <author>International Journal of Oral and Maxillofacial Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315418</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5315418</guid>        </item>
        <item>
            <title>Efficacy of amoxicillin/clavulanic acid 2000/125mg in preventing infection after extraction of impacted mandibular third molar totally covered by bone: preliminary results</title>
            <link>http://www.medworm.com/index.php?rid=5315424&amp;cid=c_31745_16_f&amp;fid=35742&amp;url=http%3A%2F%2Fwww.ijoms.com%2Farticle%2FPIIS0901502711003432%2Fabstract%3Frss%3Dyes</link>
            <description>Objective: To evaluate the effectiveness of systemic antibiotic prophylaxis 2g amoxicillin/125 clavulanic acid in preventing infection after extracting inferior third molars totally covered by bone in healthy adults. (Source: International Journal of Oral and Maxillofacial Surgery)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>International Journal of Oral and Maxillofacial Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315424</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5315424</guid>        </item>
        <item>
            <title>Diagnosis and treatment of acute uncomplicated cystitis.</title>
            <link>http://www.medworm.com/index.php?rid=5335847&amp;cid=c_31745_35_f&amp;fid=28825&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22010614%26dopt%3DAbstract</link>
            <description>Authors: Colgan R, Williams M
    Abstract
    Urinary tract infections are the most common bacterial infections in women. Most urinary tract infections are acute uncomplicated cystitis. Identifiers of acute uncomplicated cystitis are frequency and dysuria in an immunocompetent woman of childbearing age who has no comorbidities or urologic abnormalities. Physical examination is typically normal or positive for suprapubic tenderness. A urinalysis, but not urine culture, is recommended in making the diagnosis. Guidelines recommend three options for first-line treatment of acute uncomplicated cystitis: fosfomycin, nitrofurantoin, and trimethoprim/sulfamethoxazole (in regions where the prevalence of Escherichia coli resistance does not exceed 20 percent). Beta-lactam antibiotics, amoxicillin/c...</description>
            <author>American Family Physician</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335847</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5335847</guid>        </item>
        <item>
            <title>Listeria peritonitis in patients on peritoneal dialysis: two cases and a review of the literature.</title>
            <link>http://www.medworm.com/index.php?rid=5383774&amp;cid=c_31745_22_f&amp;fid=36793&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22058269%26dopt%3DAbstract</link>
            <description>Authors: Bierhoff M, Krutwagen E, van Bommel EF, Verburgh CA
    Abstract
    Two cases are reported of patients on continuous ambulatory peritoneal dialysis who presented with peritonitis caused by Listeria monocytogenes. They were successfully treated with intraperitoneal and intravenous administration of amoxicillin. In patients on peritoneal dialysis, Listeria monocytogenes is a very rare cause of peritonitis, with only 11 cases reported to date, and mainly occurring in immunocompromised patients. In contrast to the majority of the reported cases, neither of our patients had received immunosuppressive drugs. To our knowledge, these are the first two cases of Listeria peritonitis reported in the Netherlands.
    PMID: 22058269 [PubMed - in process] (Source: The Netherlands Journal of Me...</description>
            <author>The Netherlands Journal of Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383774</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383774</guid>        </item>
        <item>
            <title>Inhibitory and bactericidal potential of crude acetone extracts of Combretum molle (Combretaceae) on drug-resistant strains of Helicobacter pylori.</title>
            <link>http://www.medworm.com/index.php?rid=5449725&amp;cid=c_31745_46_f&amp;fid=37922&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22106749%26dopt%3DAbstract</link>
            <description>Authors: Njume C, Afolayan AJ, Samie A, Ndip RN
    Abstract
    Infection with Helicobacter pylori is strongly associated with a number of gastroduodenal pathologies. Antimicrobial resistance to commonly-used drugs has generated a considerable interest in the search for novel therapeutic compounds from medicinal plants. As an ongoing effort of this search, the susceptibility of 32 clinical strains of H. pylori and a reference strain-NCTC 11,638-was evaluated against five solvent extracts of Combretum molle, a plant widely used for the treatment of gastric ulcers and other stomach-related morbidities in South Africa. The extracts were screened for activity by the agar-well diffusion method, and the most active one of them was tested against the same strains by micro-broth dilution and time...</description>
            <author>Journal of Health, Population, and Nutrition</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449725</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5449725</guid>        </item>
        <item>
            <title>The Authors' reply</title>
            <link>http://www.medworm.com/index.php?rid=5274635&amp;cid=c_31745_17_f&amp;fid=30381&amp;url=http%3A%2F%2Fgut.bmj.com%2Fcgi%2Fcontent%2Fshort%2F60%2F11%2F1605-a%3Frss%3D1</link>
            <description>We thank Drs Molina-Infante and Gisbert1 for their letter and for their appreciation of our study.2 We completely agree that the discrepancy between their study and our study as to the efficacy of levofloxacin-containing sequential treatment in Helicobacter pylori eradication might be at least in part due to the very low (ie, 3%) prevalence of H pylori strains resistant to this antimicrobial in our region compared with their geographical area. We also agree that clarithromycin-containing sequential treatment is achieving disappointing results in areas with a high prevalence of clarithromycin and/or dual (ie, metronidazole + clarithromycin) resistance and that, therefore, its role in this setting should be critically reconsidered. Recently, a study by Hsu et al has demonstrated high efficac...</description>
            <author>Gut</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5274635</comments>
            <pubDate>Fri, 30 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5274635</guid>        </item>
    </channel>
</rss>

